1
|
Min SE, Gu EY, Jung J, Back SM, Kim W, Min BS, Kim YB, Han KH. Evaluating the toxicity of the roots of Asarum heterotropoides var. mandshuricum extracted using the decoction method: Genotoxicity, single-dose toxicity, and 13-week repeated-dose toxicity studies. J Ethnopharmacol 2024; 325:117783. [PMID: 38246480 DOI: 10.1016/j.jep.2024.117783] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/05/2023] [Revised: 01/12/2024] [Accepted: 01/15/2024] [Indexed: 01/23/2024]
Abstract
ETHNOPHARMACOLOGICAL RELEVANCE The roots of Asarum heterotropoides F. Maekawa var. mandshuricum F. Maekawa (AR) is a traditional herbal medicine used across Asia, including Korea, China, and Japan. AR exhibits a range of biological activities, such as anti-inflammatory, anti-cancer, cold treatment, and anti-nociceptive effects. Various extraction methods, including decoction, which utilizes traditional knowledge and techniques. The AR decoction extract expected to contain fewer toxicants and have reduced toxicity due to the use of hot water in the extraction process. However, scientific evidence on the toxicity of AR decoction extracts is lacking, necessitating further studies for safe usage. AIM OF THE STUDY This study aimed to evaluate the genotoxicity and toxicity of single and repeated administration of AR decoction extracts. MATERIALS AND METHODS The genotoxicity was assessed using a bacterial reverse mutation (Ames test), an in vitro mammalian chromosome aberration test (CA test), and an in vivo micronucleus test (MN test) in Sprague-Dawley (SD) rats. The general toxicity was evaluated through single-dose and 13-week repeated-dose toxicity studies. In the single-dose toxicity study, 40 SD rats were orally administered AR decoction extract at doses of 1000, 2000, and 5000 mg/kg. In the 13-week repeated-dose toxicity study, 140 SD rats received daily oral doses of 0, 250, 500, 1000, 2000, and 5000 mg/kg of AR decoction extract. RESULTS The genotoxicity tests revealed that AR decoction extract was not genotoxic. The single-dose toxicity study showed no changes in body weight, clinical pathology, or macroscopic findings, with the approximate lethal dose (ALD) exceeding 5000 mg/kg. The 13-week repeated-dose toxicity study demonstrated no treatment-related changes in body weight, general symptoms, hematology, clinical chemistry, or urinalysis. Histopathological findings revealed hyperplasia of squamous cells in the forestomach after AR decoction extract administration, a treatment-related effect that resolved during the recovery period. The no observed adverse effect level (NOAEL) for both male and female rats was estimated to be 2000 mg/kg. CONCLUSIONS This study establishes the non-toxic dose of AR decoction extract, providing a foundation for further non-clinical and clinical evaluations AR safety.
Collapse
Affiliation(s)
- Seung Eui Min
- Human and Environmental Toxicology, Korea National University of Science and Technology, 217 Gajeong-ro, Yuseong-gu, Daejeon, 34113, Republic of Korea; Department of Advanced Toxicology Research, Korea Institute of Toxicology, 141 Gajeong-ro, Yuseong-gu, Daejeon, 34114, Republic of Korea.
| | - Eun-Young Gu
- Department of Advanced Toxicology Research, Korea Institute of Toxicology, 141 Gajeong-ro, Yuseong-gu, Daejeon, 34114, Republic of Korea.
| | - Jina Jung
- Carbon Neutrality & Chemical Regulatory Compliance Division, Korea Testing & Research Institute, 98, Gyoyukwon-ro, Gwacheon-si, Gyeonggido, 13810, Republic of Korea.
| | - Seng-Min Back
- Department of Advanced Toxicology Research, Korea Institute of Toxicology, 141 Gajeong-ro, Yuseong-gu, Daejeon, 34114, Republic of Korea.
| | - Woojin Kim
- Department of Advanced Toxicology Research, Korea Institute of Toxicology, 141 Gajeong-ro, Yuseong-gu, Daejeon, 34114, Republic of Korea.
| | - Byung Sun Min
- College of Pharmacy, Daegu Catholic University, Gyeongsan, Gyeongbuk, 38430, Republic of Korea.
| | - Yong-Bum Kim
- Department of Advanced Toxicology Research, Korea Institute of Toxicology, 141 Gajeong-ro, Yuseong-gu, Daejeon, 34114, Republic of Korea.
| | - Kang-Hyun Han
- Human and Environmental Toxicology, Korea National University of Science and Technology, 217 Gajeong-ro, Yuseong-gu, Daejeon, 34113, Republic of Korea; Department of Advanced Toxicology Research, Korea Institute of Toxicology, 141 Gajeong-ro, Yuseong-gu, Daejeon, 34114, Republic of Korea.
| |
Collapse
|
2
|
Son A, Kim W, Lee W, Park J, Kim H. Applicability of selected reaction monitoring for precise screening tests. Expert Rev Proteomics 2024. [PMID: 38697802 DOI: 10.1080/14789450.2024.2350975] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/27/2023] [Accepted: 03/27/2024] [Indexed: 05/05/2024]
Abstract
INTRODUCTION The proactive identification of diseases through screening tests has long been endorsed as a means to preempt symptomatic onset. However, such screening endeavors are fraught with complications, such as diagnostic inaccuracies, procedural risks, and patient unease during examinations. These challenges are amplified when screenings for multiple diseases are administered concurrently. Selected Reaction Monitoring (SRM) offers a unique advantage, allowing for the high-throughput quantification of hundreds of analytes with minimal interferences. AREAS COVERED Our research posits that SRM-based assays, traditionally tailored for single-disease biomarker profiling, can be repurposed for multi-disease screening. This innovative approach has the potential to substantially alleviate time, labor, and cost demands on healthcare systems and patients alike. Nonetheless, there are formidable methodological hurdles to overcome. These include difficulties in detecting low-abundance proteins and the risk of model overfitting due to the multiple functionalities of single proteins across different disease spectrums - issues especially pertinent in blood-based assays where detection sensitivity is constrained. As we move forward, technological strides in sample preparation, online extraction, throughput, and automation are expected to ameliorate these limitations. EXPERT OPINION The maturation of mass spectrometry's integration into clinical laboratories appears imminent, positioning it as an invaluable asset for delivering highly sensitive, reproducible, and precise diagnostic results.
Collapse
Affiliation(s)
- Ahrum Son
- Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA, USA
| | | | | | | | - Hyunsoo Kim
- Department of Bio-AI convergence
- Department of Convergent Bioscience and Informatics, Chungnam National University, Daejeon, Republic of Korea
- SCICS, Daejeon, Republic of Korea
| |
Collapse
|
3
|
Kim S, Jeong JS, Kim W, Ham O, Quah Y, Jung S, Park DJ, Kim MJ, Han BC, Kim E, Lee SJ, Yu WJ. Assessing systemic, developmental, and reproductive toxicity and estrogenicity of Korean red ginseng extract G1899 in juvenile Sprague-Dawley Rats. J Ginseng Res 2024; 48:333-340. [PMID: 38707647 PMCID: PMC11068984 DOI: 10.1016/j.jgr.2024.01.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/29/2023] [Revised: 01/03/2024] [Accepted: 01/10/2024] [Indexed: 05/07/2024] Open
Abstract
Background Korean red ginseng (KRG) is a product from ginseng roots, which is enriched with ginsenosides and has been utilized for a long time as an adaptogen to alleviate various physiological or disease conditions. While KRG is generally considered safe, conducting a thorough toxicological assessment of the spray-dried powder G1899 during the juvenile period is essential to establish its safety profile. This study aimed to assess the safety of G1899 during the juvenile period using Sprague-Dawley rats. Methods Two studies were conducted separately: a juvenile toxicity study and a uterotrophic bioassay. To assess the potential toxicity at systemic, postnatal developmental, and reproductive levels, G1899 was orally gavaged once a day in post-weaning juvenile Sprague-Dawley (SD) rats at 0, 1250, 2500, or 5000 mg/kg/day. Estrogenicity was assessed by orally gavaging G1899 in immature female SD rats at 0, 2500, or 5000 mg/kg/day on postnatal days (PND) 19-21, followed by a uterotrophic bioassay. These studies were conducted in accordance with the Good Laboratory Practice (GLP) regulations and regulatory test guidelines. Results Regarding juvenile toxicity, no abnormalities related to the G1899 treatment were observed in any group during the experiment. Moreover, no uterotrophic responses were observed in the dosed female group. Based on these results, the no observed adverse effect level (NOAEL) of G1899 was determined to be at least 5000 mg/kg/day for general systemic function, developmental/reproductive function, and estrogenic activity. Conclusion Our results suggest that G1899 is not toxic to juveniles at doses of up to 5000 mg/kg/day.
Collapse
Affiliation(s)
- Sangyun Kim
- Developmental and Reproductive Toxicology Research Group, Korea Institute of Toxicology, Daejeon, Republic of Korea
| | - Ji-Seong Jeong
- Developmental and Reproductive Toxicology Research Group, Korea Institute of Toxicology, Daejeon, Republic of Korea
| | - Woojin Kim
- Developmental and Reproductive Toxicology Research Group, Korea Institute of Toxicology, Daejeon, Republic of Korea
| | - Onju Ham
- Developmental and Reproductive Toxicology Research Group, Korea Institute of Toxicology, Daejeon, Republic of Korea
| | - Yixian Quah
- Developmental and Reproductive Toxicology Research Group, Korea Institute of Toxicology, Daejeon, Republic of Korea
| | - Soontag Jung
- Developmental and Reproductive Toxicology Research Group, Korea Institute of Toxicology, Daejeon, Republic of Korea
| | - Dong-Ju Park
- Developmental and Reproductive Toxicology Research Group, Korea Institute of Toxicology, Daejeon, Republic of Korea
| | - Min Jae Kim
- Developmental and Reproductive Toxicology Research Group, Korea Institute of Toxicology, Daejeon, Republic of Korea
| | - Byung-Cheol Han
- R&D Headquarters, Korea Ginseng Corp., Gyeonggi-do, Republic of Korea
| | - Eunji Kim
- R&D Headquarters, Korea Ginseng Corp., Gyeonggi-do, Republic of Korea
| | - Seung-Jin Lee
- Developmental and Reproductive Toxicology Research Group, Korea Institute of Toxicology, Daejeon, Republic of Korea
| | - Wook-Joon Yu
- Developmental and Reproductive Toxicology Research Group, Korea Institute of Toxicology, Daejeon, Republic of Korea
| |
Collapse
|
4
|
Lee YJ, Kim W, Hong S, Lee YJ, Lee JY, Kim SW, Kim S, Kim YT, Nam EJ. The effectiveness of CA125 and HE4 as clinical prognostic markers in epithelial ovarian cancer patients with BRCA mutation. J Gynecol Oncol 2024; 35:35.e80. [PMID: 38670560 DOI: 10.3802/jgo.2024.35.e80] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2023] [Revised: 02/14/2024] [Accepted: 03/11/2024] [Indexed: 04/28/2024] Open
Abstract
OBJECTIVE To investigate the efficacy of cancer antigen 125 (CA125) and human epididymis protein 4 (HE4) in predicting survival outcomes based on breast cancer gene (BRCA) mutational status in epithelial ovarian cancer. METHODS Medical records of 448 patients diagnosed with epithelial ovarian cancer at a single tertiary institution in Korea were retrospectively analyzed. Area under the curve, sensitivity, specificity, and accuracy were assessed using the CA125 and HE4 values after surgery and 3 cycles of chemotherapy to predict 1-year survival based on the BRCA mutational status. Kaplan-Meier analysis was used to obtain progression-free and overall survival to evaluate CA125 and HE4 effectiveness in predicting survival outcomes. RESULTS A total of 423 patients were analyzed, including 180 (42.6%) who underwent interval debulking surgery (IDS) and 243 (57.4%) who underwent primary debulking surgery (PDS). BRCA mutations were observed in 37 (15.2%) and 44 (22.4%) patients in the PDS and IDS groups, respectively. CA125 and HE4 normalization demonstrated the highest specificity in patients with or without BRCA mutations, with specificities of 97.1% and 99.1% in the PDS group and 78.6% and 86.2% in the IDS group, respectively. Normalizing HE4 alone may be an effective prognostic marker, with an area under the curve of 0.774 and specificity of 75.0%, in patients with BRCA mutations. CONCLUSION Normalizing both biomarkers emerged as the most effective predictive marker for the 1-year recurrence rate, regardless of BRCA mutational status. A negative HE4 value can be a useful predictor for 1-year recurrence-free survival in patients with BRCA mutations.
Collapse
Affiliation(s)
- Young Joo Lee
- Department of Obstetrics and Gynecology, Women's Cancer Center, Yonsei Cancer Center, Institute of Women's Life Medical Science, Yonsei University College of Medicine, Seoul, Korea
| | - Woojin Kim
- Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Korea
- Korea Medical Institute, Seoul, Korea
| | - Soomin Hong
- Department of Obstetrics and Gynecology, Women's Cancer Center, Yonsei Cancer Center, Institute of Women's Life Medical Science, Yonsei University College of Medicine, Seoul, Korea
| | - Yong Jae Lee
- Department of Obstetrics and Gynecology, Women's Cancer Center, Yonsei Cancer Center, Institute of Women's Life Medical Science, Yonsei University College of Medicine, Seoul, Korea
| | - Jung-Yun Lee
- Department of Obstetrics and Gynecology, Women's Cancer Center, Yonsei Cancer Center, Institute of Women's Life Medical Science, Yonsei University College of Medicine, Seoul, Korea
| | - Sang Wun Kim
- Department of Obstetrics and Gynecology, Women's Cancer Center, Yonsei Cancer Center, Institute of Women's Life Medical Science, Yonsei University College of Medicine, Seoul, Korea
| | - Sunghoon Kim
- Department of Obstetrics and Gynecology, Women's Cancer Center, Yonsei Cancer Center, Institute of Women's Life Medical Science, Yonsei University College of Medicine, Seoul, Korea
| | - Young Tae Kim
- Department of Obstetrics and Gynecology, Women's Cancer Center, Yonsei Cancer Center, Institute of Women's Life Medical Science, Yonsei University College of Medicine, Seoul, Korea
| | - Eun Ji Nam
- Department of Obstetrics and Gynecology, Women's Cancer Center, Yonsei Cancer Center, Institute of Women's Life Medical Science, Yonsei University College of Medicine, Seoul, Korea.
| |
Collapse
|
5
|
Bhayana R, Biswas S, Cook TS, Kim W, Kitamura FC, Gichoya J, Yi PH. From Bench to Bedside With Large Language Models: AJR Expert Panel Narrative Review. AJR Am J Roentgenol 2024. [PMID: 38598354 DOI: 10.2214/ajr.24.30928] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/12/2024]
Abstract
Large language models (LLMs) hold immense potential to revolutionize radiology. However, their integration into practice requires careful consideration. Artificial intelligence (AI) chatbots and general-purpose LLMs have potential pitfalls related to privacy, transparency, and accuracy, limiting their current clinical readiness. Thus, LLM-based tools must be optimized for radiology practice to overcome these limitations. While research and validation for radiology applications remain in their infancy, commercial products incorporating LLMs are becoming available alongside promises of transforming practice. To help radiologists navigate this landscape, this AJR Expert Panel Narrative Review provides a multidimensional perspective on LLMs, encompassing considerations from bench (development and optimization) to bedside (use in practice). At present, LLMs are not autonomous entities that can replace expert decision-making, and radiologists remain responsible for the content of their reports. Patient-facing tools, particularly medical AI chatbots, require additional guardrails to ensure safety and prevent misuse. Still, if responsibly implemented, LLMs are well-positioned to transform efficiency and quality in radiology. Radiologists must be well-informed and proactively involved in guiding the implementation of LLMs in practice to mitigate risks and maximize benefits to patient care.
Collapse
Affiliation(s)
- Rajesh Bhayana
- University Medical Imaging Toronto, Joint Department of Medical Imaging, University Health Network, University of Toronto, Toronto, ON, Canada
| | - Som Biswas
- Department of Radiology, Le Bonheur Children's Hospital, University of Tennessee Health Science Center, Memphis, TN, USA
| | - Tessa S Cook
- Department of Radiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA
| | - Woojin Kim
- Department of Radiology, Palo Alto VA Medical Center, Palo Alto, CA
| | - Felipe C Kitamura
- Department of Diagnostic Imaging, Universidade Federal de São Paulo, São Paulo, Brazil
- Dasa, São Paulo, Brazil
| | - Judy Gichoya
- Department of Radiology, Emory University School of Medicine, Georgia, U.S.A
| | - Paul H Yi
- Department of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of Medicine, Baltimore, MD
| |
Collapse
|
6
|
Lee DU, Kayumov M, Park J, Park SK, Kang Y, Ahn Y, Kim W, Yoo SH, Park JK, Kim BG, Oh YS, Jeong IS, Choi DY. Antibiofilm and antithrombotic hydrogel coating based on superhydrophilic zwitterionic carboxymethyl chitosan for blood-contacting devices. Bioact Mater 2024; 34:112-124. [PMID: 38204564 PMCID: PMC10777421 DOI: 10.1016/j.bioactmat.2023.12.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/30/2023] [Revised: 12/11/2023] [Accepted: 12/11/2023] [Indexed: 01/12/2024] Open
Abstract
Blood-contacting devices must be designed to minimize the risk of bloodstream-associated infections, thrombosis, and intimal lesions caused by surface friction. However, achieving effective prevention of both bloodstream-associated infections and thrombosis poses a challenge due to the conflicting nature of antibacterial and antithrombotic activities, specifically regarding electrostatic interactions. This study introduced a novel biocompatible hydrogel of sodium alginate and zwitterionic carboxymethyl chitosan (ZW@CMC) with antibacterial and antithrombotic activities for use in catheters. The ZW@CMC hydrogel demonstrates a superhydrophilic surface and good hygroscopic properties, which facilitate the formation of a stable hydration layer with low friction. The zwitterionic-functionalized CMC incorporates an additional negative sulfone group and increased negative charge density in the carboxyl group. This augmentation enhances electrostatic repulsion and facilitates the formation of hydration layer. This leads to exceptional prevention of blood clotting factor adhesion and inhibition of biofilm formation. Subsequently, the ZW@CMC hydrogel exhibited biocompatibility with tests of in vitro cytotoxicity, hemolysis, and catheter friction. Furthermore, in vivo tests of antithrombotic and systemic inflammation models with catheterization indicated that ZW@CMC has significant advantages for practical applications in cardiovascular-related and sepsis treatment. This study opens a new avenue for the development of chitosan-based multifunctional hydrogel for applications in blood-contacting devices.
Collapse
Affiliation(s)
- Dong Uk Lee
- Biomedical Manufacturing Technology Center, Korea Institute of Industrial Technology, Yeongcheon, 38822, Republic of Korea
| | - Mukhammad Kayumov
- Department of Thoracic and Cardiovascular Surgery, Chonnam National University Hospital and Medical School, Gwangju, 61469, Republic of Korea
| | - Junghun Park
- Biomedical Manufacturing Technology Center, Korea Institute of Industrial Technology, Yeongcheon, 38822, Republic of Korea
| | - Se Kye Park
- Biomedical Manufacturing Technology Center, Korea Institute of Industrial Technology, Yeongcheon, 38822, Republic of Korea
| | - Yeongkwon Kang
- Research Institute of Advanced Materials, Seoul National University, Seoul, 08826, Republic of Korea
| | - Yejin Ahn
- Department of Organic and Nano System Engineering, Konkuk University, Seoul, 05029, Republic of Korea
| | - Woojin Kim
- Biomedical Manufacturing Technology Center, Korea Institute of Industrial Technology, Yeongcheon, 38822, Republic of Korea
| | - Seung Hwa Yoo
- Department of Quantum System Engineering, Jeonbuk National University, Jeonju-si, 54896, Republic of Korea
| | | | - Bong-Gi Kim
- Department of Organic and Nano System Engineering, Konkuk University, Seoul, 05029, Republic of Korea
| | - Yong Suk Oh
- Department of Mechanical Engineering, Changwon National University, Changwon, 51140, Republic of Korea
| | - In-Seok Jeong
- Department of Thoracic and Cardiovascular Surgery, Chonnam National University Hospital and Medical School, Gwangju, 61469, Republic of Korea
| | - Dong Yun Choi
- Biomedical Manufacturing Technology Center, Korea Institute of Industrial Technology, Yeongcheon, 38822, Republic of Korea
| |
Collapse
|
7
|
Kim JH, Kwak W, Nam Y, Baek J, Lee Y, Yoon S, Kim W. Effect of postbiotic Lactiplantibacillus plantarum LRCC5314 supplemented in powdered milk on type 2 diabetes in mice. J Dairy Sci 2024:S0022-0302(24)00627-1. [PMID: 38554828 DOI: 10.3168/jds.2023-24103] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/20/2023] [Accepted: 02/20/2024] [Indexed: 04/02/2024]
Abstract
Type 2 diabetes (T2D) is a chronic multifactorial disease characterized by a combination of insulin resistance and impaired glucose regulation. The alleviative effects of probiotics on T2D have been widely studied. However, studies on the effects of postbiotics, known as inactivated probiotics, on dairy products are limited. This study aimed to evaluate the effectiveness of postbiotic Lactiplantibacillus plantarum LRCC5314 in milk powder (MP-LRCC5314) in a stress-T2D mouse model. Compared with probiotic MP-LRCC5314, postbiotic MP-LRCC5314 significantly influenced stress-T2D-related factors. The administration of heat-killed MP-LRCC5314 reduced corticosterone levels, increased short-chain fatty acid production by modulating gut microbiota, and regulated immune response, glucose metabolism, stress-T2D-related biomarkers in the brain, gut, and adipose tissues, as well as glucose and insulin sensitivity. Additionally, heat-killed MP-LRCC5314 treatment led to a decrease in pro-inflammatory cytokine levels and an increase in anti-inflammatory cytokine levels. Overall, these findings suggest that adding postbiotic MP-LRCC5314 to milk powder could serve as a potential supplement for stress-T2D mitigation.
Collapse
Affiliation(s)
- J-H Kim
- Department of Microbiology, Chung-Ang University College of Medicine, Seoul 06974, Republic of Korea; LuxBiome Co. Ltd., Seoul 06974, Republic of Korea
| | - W Kwak
- Department of Microbiology, Chung-Ang University College of Medicine, Seoul 06974, Republic of Korea; Lotte R&D Center, Seoul 07594, Republic of Korea
| | - Y Nam
- Department of Microbiology, Chung-Ang University College of Medicine, Seoul 06974, Republic of Korea
| | - J Baek
- Department of Microbiology, Chung-Ang University College of Medicine, Seoul 06974, Republic of Korea
| | - Y Lee
- Department of Microbiology, Chung-Ang University College of Medicine, Seoul 06974, Republic of Korea
| | - S Yoon
- Lotte R&D Center, Seoul 07594, Republic of Korea
| | - W Kim
- Department of Microbiology, Chung-Ang University College of Medicine, Seoul 06974, Republic of Korea; LuxBiome Co. Ltd., Seoul 06974, Republic of Korea.
| |
Collapse
|
8
|
Kim M, Kim Y, Kim AR, Kwon WJ, Lim S, Kim W, Yoo C. Cooking oil fume exposure and Lung-RADS distribution among school cafeteria workers of South Korea. Ann Occup Environ Med 2024; 36:e2. [PMID: 38379639 PMCID: PMC10874949 DOI: 10.35371/aoem.2024.36.e2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/08/2023] [Revised: 09/29/2023] [Accepted: 01/03/2024] [Indexed: 02/22/2024] Open
Abstract
Background Cooking oil fumes (COFs) from cooking with hot oil may contribute to the pathogenesis of lung cancer. Since 2021, occupational lung cancer for individual cafeteria workers has been recognized in South Korea. In this study, we aimed to identify the distribution of lung-imaging reporting and data system (Lung-RADS) among cafeteria workers and to determine factors related to Lung-RADS distribution. Methods We included 203 female participants who underwent low-dose computed tomography (LDCT) screening at a university hospital and examined the following variables: age, smoking status, second-hand smoke, height, weight, and years of service, mask use, cooking time, heat source, and ventilation. We divided all participants into culinary and non-culinary workers. Binomial logistic regression was conducted to determine the risk factors on LDCT of Category ≥ 3, separately for the overall group and the culinary group. Results In this study, Lung-RADS-positive occurred in 17 (8.4%) individuals, all of whom were culinary workers. Binary logistic regression analyses were performed and no variables were found to have a significant impact on Lung-RADS results. In the subgroup analysis, the Lung-RADS-positive, and -negative groups differed only in ventilation. Binary logistic regression showed that the adjusted odds ratio (aOR) of the Lung-RADS-positive group for inappropriate ventilation at the workplace was 14.89 (95% confidence interval [CI]: 3.296-67.231) compared to appropriate ventilation as the reference, and the aOR for electric appliances at home was 4.59 (95% CI: 1.061-19.890) using liquid fuel as the reference. Conclusions The rate of Lung-RADS-positive was significantly higher among culinary workers who performed actual cooking tasks than among nonculinary workers. In addition, appropriate ventilation at the workplace made the LDCT results differ. More research is needed to identify factors that might influence LDCT findings among culinary workers, including those in other occupations.
Collapse
Affiliation(s)
- Minjun Kim
- Department of Occupational and Environmental Medicine, Ulsan University Hospital, Ulsan University School of Medicine, Ulsan, Korea
| | - Yangho Kim
- Department of Occupational and Environmental Medicine, Ulsan University Hospital, Ulsan University School of Medicine, Ulsan, Korea
| | - A Ram Kim
- Department of Occupational and Environmental Medicine, Ulsan University Hospital, Ulsan University School of Medicine, Ulsan, Korea
| | - Woon Jung Kwon
- Department of Diagnostic Radiology, Ulsan University Hospital, Ulsan University School of Medicine, Ulsan, Korea
| | - Soyeoun Lim
- Department of Diagnostic Radiology, Ulsan University Hospital, Ulsan University School of Medicine, Ulsan, Korea
| | - Woojin Kim
- Department of Occupational and Environmental Medicine, Ulsan University Hospital, Ulsan University School of Medicine, Ulsan, Korea
| | - Cheolin Yoo
- Department of Occupational and Environmental Medicine, Ulsan University Hospital, Ulsan University School of Medicine, Ulsan, Korea
| |
Collapse
|
9
|
Lee J, Han BC, Kim W, Shin SH, Jeong JS, Yixian Q, Yu WJ. Juvenile toxicity study of deer antler extract in rats. J Ethnopharmacol 2024; 319:117094. [PMID: 37648178 DOI: 10.1016/j.jep.2023.117094] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/11/2023] [Revised: 08/22/2023] [Accepted: 08/24/2023] [Indexed: 09/01/2023]
Abstract
ETHNOPHARMACOLOGICAL RELEVANCE Deer (Cervus elaphus Linnaeus) antler extract has been traditionally used in many Asian countries to prevent and treat various diseases. Deer antler extract is generally considered to be safe because humans have been exposed to it for a long time and it has been used as a tonic medicine originating from naturally occurring product. However, the comprehensive toxicological potential of deer antler extract during the juvenile period has not been investigated and its safety for juveniles remains unclear. AIM OF THE STUDY The aim of the present study was to comprehensively investigate the potential toxicological effects of deer antler extract during the juvenile period. MATERIALS AND METHODS As part of a safety assessment of the juvenile period, two separate studies, a juvenile toxicity study and a uterotrophic bioassay, were conducted in accordance with Good Laboratory Practice regulations and test guidelines. In the juvenile toxicity study, deer antler extract was administered daily by oral gavage to Sprague-Dawley rats at doses of 0, 500, 1000, and 2000 mg/kg during the juvenile period to investigate potential toxicities on general systemic, developmental, and reproductive functions. For the uterotrophic bioassay, deer antler extract was administered daily by oral gavage to Sprague-Dawley rats at doses of 0, 1000, and 2000 mg/kg on postnatal days 19-21 to investigate the estrogen-mimicking effects. RESULTS The results showed that deer antler extract was non-toxic and no observable adverse effects on general systemic function, developmental and reproductive function, and estrogen-mimetic effects were observed with dosing up to 2000 mg/kg during the juvenile period. CONCLUSION The safety of deer antler extracts was demonstrated in these studies and the results of this study can be used to evaluate human risk or determine the maximum recommended starting dose of deer antler extract for further clinical trials.
Collapse
Affiliation(s)
- Jinsoo Lee
- Developmental and Reproductive Toxicology Research Group, Korea Institute of Toxicology, Daejeon, Republic of Korea; Laboratory Animal Medicine, College of Veterinary Medicine, Chungnam National University, Daejeon, Republic of Korea.
| | - Byung-Cheol Han
- R&D Headquarters, Korea Ginseng Corp, Daejeon, Republic of Korea.
| | - Woojin Kim
- Developmental and Reproductive Toxicology Research Group, Korea Institute of Toxicology, Daejeon, Republic of Korea.
| | - Seung-Hyuk Shin
- Jeonbuk Branch Institute, Korea Institute of Toxicology, Jeongeup, Republic of Korea.
| | - Ji-Seong Jeong
- Developmental and Reproductive Toxicology Research Group, Korea Institute of Toxicology, Daejeon, Republic of Korea.
| | - Quah Yixian
- Developmental and Reproductive Toxicology Research Group, Korea Institute of Toxicology, Daejeon, Republic of Korea.
| | - Wook-Joon Yu
- Developmental and Reproductive Toxicology Research Group, Korea Institute of Toxicology, Daejeon, Republic of Korea.
| |
Collapse
|
10
|
Viennet T, Yin M, Jayaraj A, Kim W, Sun ZYJ, Fujiwara Y, Zhang K, Seruggia D, Seo HS, Dhe-Paganon S, Orkin SH, Arthanari H. Structural Insights into the DNA-Binding Mechanism of BCL11A: The Integral Role of ZnF6. bioRxiv 2024:2024.01.17.576058. [PMID: 38293057 PMCID: PMC10827156 DOI: 10.1101/2024.01.17.576058] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/01/2024]
Abstract
The transcription factor BCL11A is a critical regulator of the switch from fetal hemoglobin (HbF: α 2 γ 2 ) to adult hemoglobin (HbA: α 2 β 2 ) during development. BCL11A binds at a cognate recognition site (TGACCA) in the γ-globin gene promoter and represses its expression. DNA-binding is mediated by a triple zinc finger domain, designated ZnF456. Here, we report comprehensive investigation of ZnF456, leveraging X-ray crystallography and NMR to determine the structures in both the presence and absence of DNA. We delve into the dynamics and mode of interaction with DNA. Moreover, we discovered that the last zinc finger of BCL11A (ZnF6) plays a special role in DNA binding and γ-globin gene repression. Our findings help account for some rare γ-globin gene promoter mutations that perturb BCL11A binding and lead to increased HbF in adults (hereditary persistence of fetal hemoglobin). Comprehending the DNA binding mechanism of BCL11A opens avenues for the strategic, structure-based design of novel therapeutics targeting sickle cell disease and β-thalassemia.
Collapse
|
11
|
Kim W. Reply to, "New Horizons: The Potential Role of OpenAI's ChatGPT in Clinical Radiology". J Am Coll Radiol 2024; 21:3-4. [PMID: 37944878 DOI: 10.1016/j.jacr.2023.10.020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2023] [Accepted: 10/09/2023] [Indexed: 11/12/2023]
|
12
|
Park KT, Jeon YJ, Kim HI, Kim W. Antinociceptive Effect of Dendrobii caulis in Paclitaxel-Induced Neuropathic Pain in Mice. Life (Basel) 2023; 13:2289. [PMID: 38137890 PMCID: PMC10744469 DOI: 10.3390/life13122289] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/26/2023] [Revised: 11/25/2023] [Accepted: 11/27/2023] [Indexed: 12/24/2023] Open
Abstract
Paclitaxel-induced neuropathic pain (PINP) is a serious adverse effect of chemotherapy. Dendrobii caulis (D. caulis) is a new food source used as herbal medicine in east Asia. We examined the antinociceptive effects of D. caulis extract on PINP and clarified the mechanism of action of transient receptor potential vanilloid 1 receptor (TRPV1) in the spinal cord. PINP was induced in male mice using multiple intraperitoneal injections of paclitaxel (total dose, 8 mg/kg). PINP was maintained from D10 to D21 when assessed for cold and mechanical allodynia. Oral administration of 300 and 500 mg/kg D. caulis relieved cold and mechanical allodynia. In addition, TRPV1 in the paclitaxel group showed increased gene and protein expression, whereas the D. caulis 300 and 500 mg/kg groups showed a significant decrease. Among various substances in D. caulis, vicenin-2 was quantified by high-performance liquid chromatography, and its administration (10 mg/kg, i.p.) showed antinociceptive effects similar to those of D. caulis 500 mg/kg. Administration of the TRPV1 antagonist capsazepine also showed antinociceptive effects similar to those of D. caulis, and D. caulis is thought to exhibit antinociceptive effects on PINP by modulating the spinal TRPV1.
Collapse
Affiliation(s)
- Keun Tae Park
- Department of Physiology, College of Korean Medicine, Kyung Hee University, Seoul 02453, Republic of Korea; (K.T.P.); (Y.J.J.)
- Korean Medicine-Based Drug Repositioning Cancer Research Center, College of Korean Medicine, Kyung Hee University, Seoul 02447, Republic of Korea
| | - Yong Jae Jeon
- Department of Physiology, College of Korean Medicine, Kyung Hee University, Seoul 02453, Republic of Korea; (K.T.P.); (Y.J.J.)
| | - Hyo In Kim
- Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA;
| | - Woojin Kim
- Department of Physiology, College of Korean Medicine, Kyung Hee University, Seoul 02453, Republic of Korea; (K.T.P.); (Y.J.J.)
- Korean Medicine-Based Drug Repositioning Cancer Research Center, College of Korean Medicine, Kyung Hee University, Seoul 02447, Republic of Korea
| |
Collapse
|
13
|
Kim W, Kim AR, Ock M, Jeon YJ, Lee H, Kim D, Kim M, Yoo C. Effects of a supportive workplace environment on the success rate for smoking cessation camp. Ann Occup Environ Med 2023; 35:e48. [PMID: 38148920 PMCID: PMC10751216 DOI: 10.35371/aoem.2023.35.e48] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2023] [Revised: 10/18/2023] [Accepted: 10/31/2023] [Indexed: 12/28/2023] Open
Abstract
Background This study was conducted to identify the success rate for smoking cessation over time after participation in a therapeutic smoking cessation camp, and to identify how participant characteristics, including a supportive workplace environment for smoking cessation (SWESC), affect the success rate for smoking cessation. Methods In all, 296 participants at smoking cessation camps in Ulsan between 2015 and 2020 were investigated. The success rates of smoking cessation after weeks 4, 6, 12, and 24 at camp were investigated. The participants were grouped as workers with an SWESC, and workers without an SWESC, and variables (age, education, household income, marital status, drinking, exercise, body mass index, morbidity, job, number of counseling sessions, cigarettes smoked per day and smoking initiation age) were investigated. Multiple logistic regression analysis was conducted at each time point. In addition, Cox regression analysis was performed to evaluate the variables affecting the success rate for smoking cessation over time. Results The smoking cessation success rate of workers with an SWESC at week 24 (90.7%) was higher than that for workers without an SWESC (60.5%). Multiple logistic regression was performed to determine the relationship between each variable and the success rates for smoking cessation at week 6, 12, and 24. SWESC was confirmed as significant (p < 0.05) variables for increased success rate for smoking cessation at all 3 time points. After adjusting for all variables, the Cox proportional hazards survival analysis showed a hazard ratio of 6.17 for SWESC (p < 0.001,; 95% confidence interval: 3.08-12.38). Conclusions At a professional treatment smoking cessation camp, participants with an SWESC showed a significantly higher success rate for smoking cessation. Supportive workplace environment for workers' health is expected to be an important factor for smoking cessation projects as well as other health promotion projects at workplace.
Collapse
Affiliation(s)
- Woojin Kim
- Department of Occupational and Environmental Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea
- Ulsan Smoking Cessation Support Center, Korean Health Promotion Institute, Ulsan, Korea
| | - A Ram Kim
- Department of Occupational and Environmental Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea
| | - Minsu Ock
- Department of Preventive Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea
| | - Young-Jee Jeon
- Department of Family Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea
| | - Heun Lee
- Department of Occupational and Environmental Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea
| | - Daehwan Kim
- Department of Occupational and Environmental Medicine, Soonchunhyang University Gumi Hospital, Soonchunhyang University College of Medicine, Gumi, Korea
| | - Minjun Kim
- Department of Occupational and Environmental Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea
| | - Cheolin Yoo
- Department of Occupational and Environmental Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea
- Ulsan Smoking Cessation Support Center, Korean Health Promotion Institute, Ulsan, Korea
| |
Collapse
|
14
|
Park KT, Ko SG, Kim W. Phlomidis Radix Extract Alleviates Paclitaxel-Induced Neuropathic Pain by Modulating Spinal TRPV1 in Mice. Plants (Basel) 2023; 12:3819. [PMID: 38005716 PMCID: PMC10674976 DOI: 10.3390/plants12223819] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/17/2023] [Revised: 11/02/2023] [Accepted: 11/07/2023] [Indexed: 11/26/2023]
Abstract
Paclitaxel is a chemotherapeutic drug reported to have excellent activity against tumors; however, various side effects, including peripheral neuropathy, limit its use in some cases. In this study, the effect of Phlomidis radix (P.Radix) extract was assessed on paclitaxel-induced cold and mechanical peripheral neuropathy in mice. Multiple paclitaxel injections (accumulative dose of 8 mg/kg, i.p.) induced increased behavioral responses to cold and mechanical stimuli in mice from D10 to D21 after the first paclitaxel injection. Cold and mechanical stimuli were performed by acetone drop and von Frey filament, respectively. Oral administrations of 25% ethanol extract of P.Radix (300 and 500 mg/kg) relieved cold and mechanical pain in a dose-dependent manner. Furthermore, among the various transient receptor potential (TRP) cation channel subfamilies, paclitaxel upregulated the spinal gene expression of transient receptor potential vanilloid 1 (TRPV1) and melastatin 4 (TRPM4), but not ankyrin 1 (TRPA1). However, 500 mg/kg but not 300 mg/kg of P.Radix extract significantly downregulated the gene expression of TRPV1 but not TRPM4. Among the components of P.Radix, sesamoside was identified and quantified by high-performance liquid chromatography (HPLC), and the administration of sesamoside (7.5 mg/kg, i.p.) showed a similar analgesic effect to 300 mg/kg P.Radix. These results suggest that P.Radix and sesamoside should be considered when treating paclitaxel-induced neuropathic pain.
Collapse
Affiliation(s)
- Keun-Tae Park
- Department of Physiology, College of Korean Medicine, Kyung Hee University, Seoul 02453, Republic of Korea;
| | - Seong-Gyu Ko
- Korean Medicine-Based Drug Repositioning Cancer Research Center, College of Korean Medicine, Kyung Hee University, Seoul 02447, Republic of Korea;
| | - Woojin Kim
- Department of Physiology, College of Korean Medicine, Kyung Hee University, Seoul 02453, Republic of Korea;
- Korean Medicine-Based Drug Repositioning Cancer Research Center, College of Korean Medicine, Kyung Hee University, Seoul 02447, Republic of Korea;
| |
Collapse
|
15
|
Kim H, Park KT, Jo H, Shin Y, Chung G, Ko SG, Jin YH, Kim W. The effect of ginger extract on cisplatin-induced acute anorexia in rats. Front Pharmacol 2023; 14:1267254. [PMID: 38026983 PMCID: PMC10665510 DOI: 10.3389/fphar.2023.1267254] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/26/2023] [Accepted: 10/30/2023] [Indexed: 12/01/2023] Open
Abstract
Cisplatin is a platinum-based chemotherapeutic agent widely used to treat various cancers. However, several side effects have been reported in treated patients. Among these, acute anorexia is one of the most severe secondary effects. In this study, a single oral administration of 100 or 500 mg/kg ginger extract (GE) significantly alleviated the cisplatin-induced decrease in food intake in rats. However, these body weight and water intake decreases were reversed in the 100 mg/kg group rats. To elucidate the underlying mechanism of action, serotonin (5-HT) and 5-HT2C, 3A, and 4 receptors in the nodose ganglion of the vagus nerve were investigated. The results showed that cisplatin-induced increases in serotonin levels in both the blood and nodose ganglion tissues were significantly decreased by100 and 500 mg/kg of GE administration. On 5-HT receptors, 5-HT3A and 4, but not 2C receptors, were affected by cisplatin, and GE 100 and 500 mg/kg succeeded in downregulating the evoked upregulated gene of these receptors. Protein expression of 5-HT3A and 4 receptors were also reduced in the 100 mg/kg group. Furthermore, the injection of 5-HT3A, and 4 receptors antagonists (palonostron, 0.1 mg/kg, i.p.; piboserod, 1 mg/kg, i.p., respectively) in cisplatin treated rats prevented the decrease in food intake. Using high-performance liquid chromatography (HPLC) analysis, [6]-gingerol and [6]-shogaol were identified and quantified as the major components of GE, comprising 4.12% and 2.15% of the GE, respectively. Although [6]-gingerol or [6]-shogaol alone failed to alleviate the evoked anorexia, when treated together, the effect was significant on the cisplatin-induced decrease in food intake. These results show that GE can be considered a treatment option to alleviate cisplatin-induced anorexia.
Collapse
Affiliation(s)
- Hyeonah Kim
- Department of Physiology, College of Korean Medicine, Kyung Hee University, Seoul, Republic of Korea
| | - Keun-Tae Park
- Department of Physiology, College of Korean Medicine, Kyung Hee University, Seoul, Republic of Korea
| | - Heejoon Jo
- Department of Physiology, College of Korean Medicine, Kyung Hee University, Seoul, Republic of Korea
| | - Yuchan Shin
- Department of Physiology, College of Korean Medicine, Kyung Hee University, Seoul, Republic of Korea
| | - Geehoon Chung
- Department of Physiology, College of Korean Medicine, Kyung Hee University, Seoul, Republic of Korea
| | - Seong-Gyu Ko
- Korean Medicine-Based Drug Repositioning Cancer Research Center, College of Korean Medicine, Kyung Hee University, Seoul, Republic of Korea
| | - Young-Ho Jin
- Department of Physiology, College of Medicine, Kyung Hee University, Seoul, Republic of Korea
| | - Woojin Kim
- Department of Physiology, College of Korean Medicine, Kyung Hee University, Seoul, Republic of Korea
- Korean Medicine-Based Drug Repositioning Cancer Research Center, College of Korean Medicine, Kyung Hee University, Seoul, Republic of Korea
| |
Collapse
|
16
|
Kim H, Kim M, Park K, Kim J, Yoon D, Kim W, Park CH. Machine learning-based classification analysis of knowledge worker mental stress. Front Public Health 2023; 11:1302794. [PMID: 38026368 PMCID: PMC10661277 DOI: 10.3389/fpubh.2023.1302794] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2023] [Accepted: 10/25/2023] [Indexed: 12/01/2023] Open
Abstract
The aim of this study is to analyze the performance of classifying stress and non-stress by measuring biosignal data using a wearable watch without interfering with work activities at work. An experiment is designed where participants wear a Galaxy Watch3 to measure HR and photoplethysmography data while performing stress-inducing and relaxation tasks. The classification model was constructed using k-NN, SVM, DT, LR, RF, and MLP classifiers. The performance of each classifier was evaluated using LOSO-CV as a verification method. When the top 9 features, including the average and minimum value of HR, average of NNI, SDNN, vLF, HF, LF, LF/HF ratio, and total power, were used in the classification model, it showed the best performance with an accuracy of 0.817 and an F1 score of 0.801. This study also finds that it is necessary to measure physiological data for more than 2 or 3 min to accurately distinguish stress states.
Collapse
Affiliation(s)
- Hyunsuk Kim
- Mobility UX Research Section, Electronics and Telecommunications Research Institute, Daejeon, Republic of Korea
| | - Minjung Kim
- Mobility UX Research Section, Electronics and Telecommunications Research Institute, Daejeon, Republic of Korea
| | - Kyounghyun Park
- Mobility UX Research Section, Electronics and Telecommunications Research Institute, Daejeon, Republic of Korea
| | - Jungsook Kim
- Mobility UX Research Section, Electronics and Telecommunications Research Institute, Daejeon, Republic of Korea
| | - Daesub Yoon
- Mobility UX Research Section, Electronics and Telecommunications Research Institute, Daejeon, Republic of Korea
| | - Woojin Kim
- Mobility UX Research Section, Electronics and Telecommunications Research Institute, Daejeon, Republic of Korea
| | - Cheong Hee Park
- Division of Computer Convergence, Chungnam National University, Daejeon, Republic of Korea
| |
Collapse
|
17
|
Gang J, Park KT, Kim S, Kim W. Involvement of the Spinal Serotonergic System in the Analgesic Effect of [6]-Shogaol in Oxaliplatin-Induced Neuropathic Pain in Mice. Pharmaceuticals (Basel) 2023; 16:1465. [PMID: 37895936 PMCID: PMC10610466 DOI: 10.3390/ph16101465] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/07/2023] [Revised: 10/01/2023] [Accepted: 10/10/2023] [Indexed: 10/29/2023] Open
Abstract
Oxaliplatin is a chemotherapy drug that can induce severe acute neuropathy in patients within hours of treatment. In our previous study, 10 mg/kg [6]-shogaol (i.p.) significantly alleviated cold and mechanical allodynia induced by a 6 mg/kg oxaliplatin injection (i.p.); however, the precise serotonin-modulatory effect has not been investigated. In this study, we showed that intrathecal injections of NAN-190 (5-HT1A receptor antagonist, 1 µg) and MDL-72222 (5-HT3 receptor antagonist, 15 µg), but not ketanserin (5-HT2A receptor antagonist, 1 µg), significantly blocked the analgesic effect of [6]-shogaol (10 mg/kg, i.p.). Furthermore, the gene expression of the serotonin-synthesizing enzyme tryptophan hydroxylase 2 (TPH2) and serotonin levels in the spinal cord and serum were significantly downregulated (p < 0.0001 and p = 0.0002) and upregulated (p = 0.0298 and p = 0.0099) after oxaliplatin and [6]-shogaol administration, respectively. Moreover, both the gene and protein expression of the spinal serotonin receptors 5-HT1A and 5-HT3 significantly increased after [6]-shogaol injections (p < 0.0001). Finally, intrathecal injections of both receptor agonists (8-OH-DPAT; 5-HT1A receptor agonist, 10 µg and m-CPBG; 5-HT3 receptor agonist, 15 µg) mimicked the effects of [6]-shogaol in oxaliplatin-injected mice. Taken together, these results demonstrate that [6]-shogaol attenuates oxaliplatin-induced neuropathic pain by modulating the spinal serotoninergic system.
Collapse
Affiliation(s)
- Juan Gang
- Department of East-West Medicine, Graduate School, Kyung Hee University, Seoul 02447, Republic of Korea;
| | - Keun-Tae Park
- Department of Physiology, College of Korean Medicine, Kyung Hee University, Seoul 02453, Republic of Korea; (K.-T.P.); (S.K.)
- Korean Medicine-Based Drug Repositioning Cancer Research Center, College of Korean Medicine, Kyung Hee University, Seoul 02447, Republic of Korea
| | - Suyong Kim
- Department of Physiology, College of Korean Medicine, Kyung Hee University, Seoul 02453, Republic of Korea; (K.-T.P.); (S.K.)
| | - Woojin Kim
- Department of East-West Medicine, Graduate School, Kyung Hee University, Seoul 02447, Republic of Korea;
- Department of Physiology, College of Korean Medicine, Kyung Hee University, Seoul 02453, Republic of Korea; (K.-T.P.); (S.K.)
- Korean Medicine-Based Drug Repositioning Cancer Research Center, College of Korean Medicine, Kyung Hee University, Seoul 02447, Republic of Korea
| |
Collapse
|
18
|
Park H, Jang MS, Choi JA, Kim W, Kim YB, Kim NH, Choi E, Son HY, Han KH. Nonclinical safety assessment and immunogenicity of rVSVInd(GML)-mspSGtc vaccine for SARS-CoV-2 in rabbits. Vaccine 2023:S0264-410X(23)01178-7. [PMID: 37821316 DOI: 10.1016/j.vaccine.2023.10.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/20/2023] [Revised: 09/26/2023] [Accepted: 10/04/2023] [Indexed: 10/13/2023]
Abstract
The worldwide health, economic, and societal consequences of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic have been devastating. The primary strategy to prevent new infectious diseases is to vaccinate the majority of people worldwide. However, the significant hurdles that are faced include vaccine safety concerns and vaccine reluctance. Among the various types of vaccines, the recombinant vesicular stomatitis virus (rVSV) is a promising candidate owing to its safety and efficacy. Therefore, we investigated the toxicity, immunogenicity, and local tolerance of the rVSVInd(GML)-mspSGtc vaccine against SARS-CoV-2. New Zealand White (NZW) rabbits were administered single or three repeated intramuscular injections of rVSVInd(GML)-mspSGtc every 2 weeks, followed by a 4-week recovery period. Male and female rabbits were randomly assigned into three groups: a control group and two dose-level groups (1 × 109 and 4 × 109 PFU/mL). Treatment-related changes included a temporary increase in body temperature and local inflammation at the injection site. These findings indicated recovery or a trend toward recovery, with no overt systemic toxicity. Immunogenicity analysis results suggested that rVSVInd(GML)-mspSGtc elicited a robust dose-dependent immune response in terms of neutralizing antibodies and IgG antibodies against the SARS-CoV-2 spike protein. In addition, the immune response intensity was increased by repeated vaccine administration. In conclusion, both the approximate lethal dose and the no observed adverse effect level for rVSVInd(GML)-mspSGtc exceeded 4 × 109 PFU/mL in NZW rabbits. Overall, rVSVInd(GML)-mspSGtc induced no adverse effects at the maximum dosage tested; however, its efficacy warrants further clinical evaluation.
Collapse
Affiliation(s)
- Heeseon Park
- Department of Advanced Toxicology Research, Korea Institute of Toxicology, 141 Gajeong-ro, Yuseong-gu, Daejeon 34114, Republic of Korea; College of Veterinary Medicine, Chungnam National University, 99 Daehak-ro, Yuseong-gu, Daejeon 34134, Republic of Korea
| | - Min Seong Jang
- Department of Advanced Toxicology Research, Korea Institute of Toxicology, 141 Gajeong-ro, Yuseong-gu, Daejeon 34114, Republic of Korea
| | - Jung-Ah Choi
- International Vaccine Institute, SNU Research Park, 1 Gwanak-ro, Gwanak-gu, Seoul, Republic of Korea
| | - Woojin Kim
- Department of Advanced Toxicology Research, Korea Institute of Toxicology, 141 Gajeong-ro, Yuseong-gu, Daejeon 34114, Republic of Korea
| | - Yong-Bum Kim
- Department of Advanced Toxicology Research, Korea Institute of Toxicology, 141 Gajeong-ro, Yuseong-gu, Daejeon 34114, Republic of Korea
| | - Na Hyung Kim
- Sumagen Co., Ltd., 4F Dongwon Building, Teheran-ro 77-gil, Gangnam-gu, Seoul 06159, Republic of Korea
| | - Eunsil Choi
- Sumagen Co., Ltd., 4F Dongwon Building, Teheran-ro 77-gil, Gangnam-gu, Seoul 06159, Republic of Korea
| | - Hwa-Young Son
- College of Veterinary Medicine, Chungnam National University, 99 Daehak-ro, Yuseong-gu, Daejeon 34134, Republic of Korea.
| | - Kang-Hyun Han
- Department of Advanced Toxicology Research, Korea Institute of Toxicology, 141 Gajeong-ro, Yuseong-gu, Daejeon 34114, Republic of Korea.
| |
Collapse
|
19
|
Kim SC, Kim DW, Cho EJ, Lee JY, Kim J, Kwon C, Kim-Ha J, Hong SK, Choi Y, Yi NJ, Lee KW, Suh KS, Kim W, Kim W, Kim H, Kim YJ, Yoon JH, Yu SJ, Kim YJ. A circulating cell-free DNA methylation signature for the detection of hepatocellular carcinoma. Mol Cancer 2023; 22:164. [PMID: 37803338 PMCID: PMC10557228 DOI: 10.1186/s12943-023-01872-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/27/2023] [Accepted: 09/26/2023] [Indexed: 10/08/2023] Open
Abstract
To address the shortcomings of current hepatocellular carcinoma (HCC) surveillance tests, we set out to find HCC-specific methylation markers and develop a highly sensitive polymerase chain reaction (PCR)-based method to detect them in circulating cell-free DNA (cfDNA). The analysis of large methylome data revealed that Ring Finger Protein 135 (RNF135) and Lactate Dehydrogenase B (LDHB) are universally applicable HCC methylation markers with no discernible methylation level detected in any other tissue types. These markers were used to develop Methylation Sensitive High-Resolution Analysis (MS-HRM), and their diagnostic accuracy was tested using cfDNA from healthy, at-risk, and HCC patients. The combined MS-HRM RNF135 and LDHB analysis detected 57% of HCC, outperforming the alpha-fetoprotein (AFP) test's sensitivity of 45% at comparable specificity. Furthermore, when used with the AFP test, the methylation assay can detect 70% of HCC. Our findings suggest that the cfDNA methylation assay could be used for HCC liquid biopsy.
Collapse
Affiliation(s)
- Si-Cho Kim
- Interdisciplinary Program of Integrated OMICS for Biomedical Science, Yonsei University, Seoul, Republic of Korea
- R&D center, LepiDyne Inc, Seoul, Republic of Korea
| | - Da-Won Kim
- Interdisciplinary Program of Integrated OMICS for Biomedical Science, Yonsei University, Seoul, Republic of Korea
- R&D center, LepiDyne Inc, Seoul, Republic of Korea
| | - Eun Ju Cho
- Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, 03080, Republic of Korea
| | - Jin-Young Lee
- Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University, Seoul, 03722, Republic of Korea
| | - Jiwon Kim
- Department of Integrative Bioscience & Biotechnology, College of Life Sciences, Sejong University, Seoul, Republic of Korea
| | - Chaesun Kwon
- Department of Integrative Bioscience & Biotechnology, College of Life Sciences, Sejong University, Seoul, Republic of Korea
| | - Jeongsil Kim-Ha
- Department of Integrative Bioscience & Biotechnology, College of Life Sciences, Sejong University, Seoul, Republic of Korea
| | - Suk Kyun Hong
- Department of Surgery, Seoul National University College of Medicine, Seoul, Republic of Korea
| | - YoungRok Choi
- Department of Surgery, Seoul National University College of Medicine, Seoul, Republic of Korea
| | - Nam-Joon Yi
- Department of Surgery, Seoul National University College of Medicine, Seoul, Republic of Korea
| | - Kwang-Woong Lee
- Department of Surgery, Seoul National University College of Medicine, Seoul, Republic of Korea
| | - Kyung-Suk Suh
- Department of Surgery, Seoul National University College of Medicine, Seoul, Republic of Korea
| | - Won Kim
- Department of Internal Medicine, Seoul National University College of Medicine, Seoul Metropolitan Government Boramae Medical Center, Seoul, Republic of Korea
| | - Woojin Kim
- Department of Bio-AI convergence, Chungnam National University, Daejeon, Republic of Korea
| | - Hyunsoo Kim
- Department of Bio-AI convergence, Chungnam National University, Daejeon, Republic of Korea
- Department of Convergent Bioscience and Informatics, Chungnam National University, Daejeon, Republic of Korea
| | - Yoon Jun Kim
- Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, 03080, Republic of Korea
| | - Jung-Hwan Yoon
- Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, 03080, Republic of Korea
| | - Su Jong Yu
- Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, 03080, Republic of Korea.
| | - Young-Joon Kim
- Interdisciplinary Program of Integrated OMICS for Biomedical Science, Yonsei University, Seoul, Republic of Korea.
- Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University, Seoul, 03722, Republic of Korea.
| |
Collapse
|
20
|
Yoo MH, Lee AR, Kim W, Yu WJ, Lee BS. Bisphenol A is more potent than bisphenol S in influencing the physiological and pathological functions of lungs via inducing lung fibrosis and stimulating metastasis. Ecotoxicol Environ Saf 2023; 264:115479. [PMID: 37716066 DOI: 10.1016/j.ecoenv.2023.115479] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/18/2023] [Revised: 08/29/2023] [Accepted: 09/12/2023] [Indexed: 09/18/2023]
Abstract
Bisphenol A (BPA) is widely used in the production of plastics, food containers, and receipt ink globally. However, research has identified it as an endocrine disruptor, affecting the hormonal balance in living organisms. Bisphenol S (BPS), one of the alternative substances, was developed, but its effects on human health and the underlying mechanisms remain unclarified. Specifically, research on the effects of oral exposure to bisphenol on the lungs is lacking. We examined the potential differences in toxicity between these compounds in lung cells in vitro and in vivo. Our toxicity mechanism studies on MRC5 and A549 cells exposed to BPA or BPS revealed that BPA induced actin filament abnormalities and activated epithelial-mesenchymal transition (EMT). This finding suggests an increased potential for lung fibrosis and metastasis in lung cancer. However, given that BPS was not detected at the administered dose and under the specific experimental conditions, the probability of these occurrences is considered minimal. Additionally, animal experiments confirmed that oral exposure to BPA activates EMT in the lungs. Our study provides evidence that prolonged oral exposure to BPA can lead to EMT activation in lung tissue, similar to that observed in cell experiments, suggesting the potential to induce lung fibrosis. This research emphasizes the importance of regulating the use of BPA to mitigate its associated pulmonary toxicity. Furthermore, it is significant that within the parameters of our experimental conditions, BPS did not exhibit the toxicological pathways clearly evident in BPA.
Collapse
Affiliation(s)
- Min Heui Yoo
- Department of Innovative Toxicology Research, Korea Institute of Toxicology, 141 Gajeon-ro, Yuseong-gu, Daejeon, Republic of Korea.
| | - A-Ram Lee
- Department of Innovative Toxicology Research, Korea Institute of Toxicology, 141 Gajeon-ro, Yuseong-gu, Daejeon, Republic of Korea; LegoChem Biosciences, 10 Gukjegwahak-ro, Yuseong-gu, Daejeon, Republic of Korea
| | - Woojin Kim
- Department of Innovative Toxicology Research, Korea Institute of Toxicology, 141 Gajeon-ro, Yuseong-gu, Daejeon, Republic of Korea
| | - Wook-Joon Yu
- Department of Innovative Toxicology Research, Korea Institute of Toxicology, 141 Gajeon-ro, Yuseong-gu, Daejeon, Republic of Korea
| | - Byoung-Seok Lee
- Department of Innovative Toxicology Research, Korea Institute of Toxicology, 141 Gajeon-ro, Yuseong-gu, Daejeon, Republic of Korea.
| |
Collapse
|
21
|
Jung W, Choi H, Kim J, Kim J, Kim W, Nurkolis F, Kim B. Effects of natural products on polycystic ovary syndrome: From traditional medicine to modern drug discovery. Heliyon 2023; 9:e20889. [PMID: 37867816 PMCID: PMC10589870 DOI: 10.1016/j.heliyon.2023.e20889] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/02/2023] [Revised: 09/24/2023] [Accepted: 10/10/2023] [Indexed: 10/24/2023] Open
Abstract
Polycystic Ovary Syndrome (PCOS) is a common endocrine disorder with a worldwide prevalence of 6-10 % of women of reproductive age. PCOS is a risk factor for cardiometabolic disorders such as type 2 diabetes, myocardial infarction, and stroke in addition to exhibiting signs of hyperandrogenism and anovulation. However, there is no known cure for PCOS, and medications have only ever been used symptomatically, with a variety of adverse effects. Drugs made from natural plant products may help treat PCOS because several plant extracts have been widely recognized to lessen the symptoms of PCOS. In light of this, 72 current studies on natural products with the potential to control PCOS were examined. By controlling the PI3K/AKT signaling pathway and decreasing NF-κB and cytokines such as tumor necrosis factor (TNF), interleukin-1 (IL-1), and interleukin-6 (IL-6), certain plant-derived chemicals might reduce inflammation. Other substances altered the HPO axis, which normalized hormones. Additionally, other plant components increased glutathione (GSH), superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx) levels to reduce radiation-induced oxidative stress. The other substances prevented autophagy by impairing beclin 1, autophagy-related 5 (ATG5), and microtubule-associated protein 1A/1B-light chain 3 - II (LC3- II). The main focus of this comprehensive review is the possibility of plant extracts as natural bio-resources of PCOS treatment by regulating inflammation, hormones, reactive oxygen species (ROS), or autophagy.
Collapse
Affiliation(s)
- Woobin Jung
- College of Korean Medicine, Kyung Hee University, Seoul, 02447, South Korea
| | - Hyojoo Choi
- College of Korean Medicine, Kyung Hee University, Seoul, 02447, South Korea
| | - Jimin Kim
- College of Korean Medicine, Kyung Hee University, Seoul, 02447, South Korea
| | - Jeongwoo Kim
- College of Korean Medicine, Kyung Hee University, Seoul, 02447, South Korea
- Department of Pathology, College of Korean Medicine, Kyung Hee University, Seoul, 02447, South Korea
- Korean Medicine-Based Drug Repositioning Cancer Research Center, College of Korean Medicine, Kyung Hee University, Seoul, 02447, South Korea
| | - Woojin Kim
- College of Korean Medicine, Kyung Hee University, Seoul, 02447, South Korea
- Korean Medicine-Based Drug Repositioning Cancer Research Center, College of Korean Medicine, Kyung Hee University, Seoul, 02447, South Korea
| | - Fahrul Nurkolis
- Department of Biological Sciences, State Islamic University of Sunan Kalijaga (UIN Sunan Kalijaga), Indonesia
| | - Bonglee Kim
- College of Korean Medicine, Kyung Hee University, Seoul, 02447, South Korea
- Department of Pathology, College of Korean Medicine, Kyung Hee University, Seoul, 02447, South Korea
- Korean Medicine-Based Drug Repositioning Cancer Research Center, College of Korean Medicine, Kyung Hee University, Seoul, 02447, South Korea
| |
Collapse
|
22
|
Kim E, Jang E, Jung W, Kim W, Lee J, Choi DH, Shin BS, Shin S, Kim TH. Establishment of an LC-MS/MS method for quantification of lifitegrast in rabbit plasma and ocular tissues and its application to pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci 2023; 1229:123892. [PMID: 37788538 DOI: 10.1016/j.jchromb.2023.123892] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2023] [Revised: 09/15/2023] [Accepted: 09/20/2023] [Indexed: 10/05/2023]
Abstract
Lifitegrast, a lymphocyte function-associated antigen 1 antagonist, was approved by the FDA for the treatment of dry eye disease. Cornea and conjunctiva have been reported to be the sites of action of lifitegrast. To investigate the pharmacokinetics of lifitegrast, a sensitive analytical method for the determination of lifitegrast in various biological matrices such as plasma and ocular tissues is required. However, only limited information about the analytical method for lifitegrast in biological samples is available. In the present study, we aimed to develop a new liquid chromatography-tandem mass spectrometry method for the determination of lifitegrast in rabbit plasma, cornea, conjunctiva, and sclera. Lifitegrast-d6 was used as an internal standard (IS). To prepare the biological samples, protein precipitation using acetonitrile was utilized. Analytes were separated from endogenous interferences on an Atlantis dC18 (5 µm, 2.1 × 150 mm), and a mixture of 0.1 % formic acid and acetonitrile was used as the mobile phase. The mass transition of precursor to product ion was monitored at 615.2 → 145.0 for lifitegrast and 621.2 → 145.1 for IS. The calibration curves were linear over the concentration range from 2 to 500 ng/mL for plasma and 5 to 500 ng/mL in ocular tissue homogenates. Intra- and inter-day accuracy ranged from 95.76 to 106.80 % in the plasma and 94.42 to 112.80 % in the ocular tissues. Precision was within 8.56 % in the plasma and 9.72 % in the ocular tissues. The short-term, long-term, auto-sampler, and freeze-thaw stabilities of lifitegrast were validated. The developed method was applied to a pharmacokinetic study of lifitegrast in rabbits. Following ophthalmic administration, only 3.26 % of administered lifitegrast was absorbed into the systemic circulation. Peak tissue concentrations were observed at 0.5 h after dosing, and topically administered lifitegrast was mainly distributed in the cornea and conjunctiva. The finding of this study is expected to be used in further pharmacokinetic studies and formulation development.
Collapse
Affiliation(s)
- Eunbin Kim
- College of Pharmacy, Daegu Catholic University, Gyeongsan, Gyeongbuk, Korea
| | - Eunbee Jang
- College of Pharmacy, Daegu Catholic University, Gyeongsan, Gyeongbuk, Korea
| | - Woohyung Jung
- College of Pharmacy, Daegu Catholic University, Gyeongsan, Gyeongbuk, Korea
| | - Woojin Kim
- College of Pharmacy, Daegu Catholic University, Gyeongsan, Gyeongbuk, Korea
| | - Jaewoong Lee
- College of Pharmacy, Daegu Catholic University, Gyeongsan, Gyeongbuk, Korea
| | - Du Hyung Choi
- College of Pharmacy, Daegu Catholic University, Gyeongsan, Gyeongbuk, Korea
| | - Beom Soo Shin
- School of Pharmacy, Sungkyunkwan University, Suwon, Gyeonggi, Korea
| | - Soyoung Shin
- College of Pharmacy, Wonkwang University, Iksan, Jeonbuk, Korea.
| | - Tae Hwan Kim
- College of Pharmacy, Daegu Catholic University, Gyeongsan, Gyeongbuk, Korea.
| |
Collapse
|
23
|
Chi KN, Sandhu S, Smith MR, Attard G, Saad M, Olmos D, Castro E, Roubaud G, Pereira de Santana Gomes AJ, Small EJ, Rathkopf DE, Gurney H, Jung W, Mason GE, Dibaj S, Wu D, Diorio B, Urtishak K, Del Corral A, Francis P, Kim W, Efstathiou E. Niraparib plus abiraterone acetate with prednisone in patients with metastatic castration-resistant prostate cancer and homologous recombination repair gene alterations: second interim analysis of the randomized phase III MAGNITUDE trial. Ann Oncol 2023; 34:772-782. [PMID: 37399894 PMCID: PMC10849465 DOI: 10.1016/j.annonc.2023.06.009] [Citation(s) in RCA: 13] [Impact Index Per Article: 13.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2023] [Revised: 06/21/2023] [Accepted: 06/22/2023] [Indexed: 07/05/2023] Open
Abstract
BACKGROUND Patients with metastatic castration-resistant prostate cancer (mCRPC) and BRCA alterations have poor outcomes. MAGNITUDE found patients with homologous recombination repair gene alterations (HRR+), particularly BRCA1/2, benefit from first-line therapy with niraparib plus abiraterone acetate and prednisone (AAP). Here we report longer follow-up from the second prespecified interim analysis (IA2). PATIENTS AND METHODS Patients with mCRPC were prospectively identified as HRR+ with/without BRCA1/2 alterations and randomized 1 : 1 to niraparib (200 mg orally) plus AAP (1000 mg/10 mg orally) or placebo plus AAP. At IA2, secondary endpoints [time to symptomatic progression, time to initiation of cytotoxic chemotherapy, overall survival (OS)] were assessed. RESULTS Overall, 212 HRR+ patients received niraparib plus AAP (BRCA1/2 subgroup, n = 113). At IA2 with 24.8 months of median follow-up in the BRCA1/2 subgroup, niraparib plus AAP significantly prolonged radiographic progression-free survival {rPFS; blinded independent central review; median rPFS 19.5 versus 10.9 months; hazard ratio (HR) = 0.55 [95% confidence interval (CI) 0.39-0.78]; nominal P = 0.0007} consistent with the first prespecified interim analysis. rPFS was also prolonged in the total HRR+ population [HR = 0.76 (95% CI 0.60-0.97); nominal P = 0.0280; median follow-up 26.8 months]. Improvements in time to symptomatic progression and time to initiation of cytotoxic chemotherapy were observed with niraparib plus AAP. In the BRCA1/2 subgroup, the analysis of OS with niraparib plus AAP demonstrated an HR of 0.88 (95% CI 0.58-1.34; nominal P = 0.5505); the prespecified inverse probability censoring weighting analysis of OS, accounting for imbalances in subsequent use of poly adenosine diphosphate-ribose polymerase inhibitors and other life-prolonging therapies, demonstrated an HR of 0.54 (95% CI 0.33-0.90; nominal P = 0.0181). No new safety signals were observed. CONCLUSIONS MAGNITUDE, enrolling the largest BRCA1/2 cohort in first-line mCRPC to date, demonstrated improved rPFS and other clinically relevant outcomes with niraparib plus AAP in patients with BRCA1/2-altered mCRPC, emphasizing the importance of identifying this molecular subset of patients.
Collapse
Affiliation(s)
- K N Chi
- University of British Columbia, BC Cancer-Vancouver Center, Vancouver, Canada.
| | - S Sandhu
- Peter MacCallum Cancer Center, Melbourne, Australia; University of Melbourne, Melbourne, Australia
| | - M R Smith
- Massachusetts General Hospital Cancer Center, Boston, USA; Harvard Medical School, Boston, USA
| | - G Attard
- University College London Cancer Institute, London, UK; University College London Hospitals, London, UK
| | - M Saad
- Department of Clinical Oncology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
| | - D Olmos
- Department of Medical Oncology, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid
| | - E Castro
- Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain
| | - G Roubaud
- Department of Medical Oncology, Institut Bergonié, Bordeaux, France
| | | | - E J Small
- Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco
| | - D E Rathkopf
- Memorial Sloan Kettering Cancer Center, New York, USA; Weill Cornell Medicine, New York, USA
| | - H Gurney
- Macquarie University, Macquarie Park, Australia
| | - W Jung
- Keimyung University Dongsan Hospital, Daegu, South Korea
| | - G E Mason
- Janssen Research & Development, LLC, Spring House
| | - S Dibaj
- Janssen Research & Development, LLC, San Diego
| | - D Wu
- Janssen Research & Development, LLC, Los Angeles
| | - B Diorio
- Janssen Research & Development, LLC, Titusville
| | - K Urtishak
- Janssen Research & Development, LLC, Spring House
| | | | - P Francis
- Janssen Research & Development, LLC, Bridgewater
| | - W Kim
- Janssen Research & Development, LLC, Los Angeles
| | | |
Collapse
|
24
|
Rothenberg S, Gupta S, Boonn W, Kim W. Translation of Artificial Intelligence Into Practice: The Radiologist as a Vendor. J Am Coll Radiol 2023; 20:875-876. [PMID: 37473853 DOI: 10.1016/j.jacr.2023.06.021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/24/2023] [Accepted: 06/14/2023] [Indexed: 07/22/2023]
Affiliation(s)
- Steven Rothenberg
- Department of Radiology, The University of Alabama at Birmingham, Heersink School of Medicine, Birmingham Alabama; is an Adjunct Assistant Professor at the Department of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of Medicine, Baltimore, Maryland; and is an Advisor at the University of Maryland Medical Intelligent Imaging (UM2ii) Center, Baltimore, Maryland.
| | - Sonia Gupta
- Abdominal Radiologist, Radiology Associates of Florida (RAF), Tampa, Florida
| | - William Boonn
- Cardiovascular Radiologist at Penn Medicine, Philadelphia, Pennsylvania; and the Chief Medical Officer at Rad AI, San Francisco, California
| | - Woojin Kim
- Musculoskeletal Radiologist at VA Palo Alto, Palo Alto, Californian; and Chief Medical Information Officer at Rad AI, San Francisco, California
| |
Collapse
|
25
|
Rim M, Kang DG, Kim W, Jang J, Oh M, Wi Y, Park S, Tran DT, Ha M, Jeong KU. Encryptable Electrochromic Smart Windows: Uniaxially Oriented and Polymerized Hierarchical Nanostructures Constructed by Self-Assembly of Tetrathiafulvalene-Based Reactive Mesogens. ACS Nano 2023. [PMID: 37486215 DOI: 10.1021/acsnano.3c02777] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 07/25/2023]
Abstract
Tetrathiafulvalene (TTF)-based reactive mesogens (TTF-E and TTF-T) are synthesized, self-assembled, uniaxially oriented, and polymerized for the development of encryptable electrochromic smart windows. Electrochemical and spectroscopic experiments prove that the self-assembled TTF mixture (TTFM, TTF-E:TTF-T = 1:1) can reversibly switch the absorption wavelength of the TTF chromophore according to the redox reactions. Based on the identification of the phase transition and crystallographic structure, uniaxially oriented hierarchical nanostructures are easily constructed on the macroscopic area by simple coating and a self-assembly process. Subsequent polymerization of hierarchical nanostructures of TTFM significantly enhances thermal and mechanical stabilities and makes it possible for them to be fabricated as an electrochromic device. The angularly dependent correlation between the anisotropy of mesogens and the linearly polarized light allow us to demonstrate TTFM as smart windows capable of various optical security applications, including privacy protection and information encryption.
Collapse
Affiliation(s)
- Minwoo Rim
- Department of Polymer-Nano Science and Technology, Department of Nano Convergence Engineering, Jeonbuk National University, Jeonju 54896, Republic of Korea
| | - Dong-Gue Kang
- Department of Chemical and Biomolecular Engineering, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States
| | - Woojin Kim
- Department of Polymer-Nano Science and Technology, Department of Nano Convergence Engineering, Jeonbuk National University, Jeonju 54896, Republic of Korea
| | - Junhwa Jang
- Department of Polymer-Nano Science and Technology, Department of Nano Convergence Engineering, Jeonbuk National University, Jeonju 54896, Republic of Korea
| | - Mintaek Oh
- Department of Polymer-Nano Science and Technology, Department of Nano Convergence Engineering, Jeonbuk National University, Jeonju 54896, Republic of Korea
| | - Youngjae Wi
- Department of Polymer-Nano Science and Technology, Department of Nano Convergence Engineering, Jeonbuk National University, Jeonju 54896, Republic of Korea
| | - Sungjune Park
- Department of Polymer-Nano Science and Technology, Department of Nano Convergence Engineering, Jeonbuk National University, Jeonju 54896, Republic of Korea
| | - Duy Thanh Tran
- Department of Polymer-Nano Science and Technology, Department of Nano Convergence Engineering, Jeonbuk National University, Jeonju 54896, Republic of Korea
| | - Minjeong Ha
- Department of Materials Science and Engineering, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of Korea
| | - Kwang-Un Jeong
- Department of Polymer-Nano Science and Technology, Department of Nano Convergence Engineering, Jeonbuk National University, Jeonju 54896, Republic of Korea
| |
Collapse
|
26
|
Diehl S, Trotta N, Joo K, Achenbach P, Akbar Z, Armstrong WR, Atac H, Avakian H, Baashen L, Baltzell NA, Barion L, Bashkanov M, Battaglieri M, Bedlinskiy I, Benmokhtar F, Bianconi A, Biselli AS, Bossù F, Brinkmann KT, Briscoe WJ, Bulumulla D, Burkert V, Capobianco R, Carman DS, Carvajal JC, Celentano A, Charles G, Chatagnon P, Chesnokov V, Ciullo G, Cole PL, Contalbrigo M, Costantini G, Crede V, D'Angelo A, Dashyan N, De Vita R, Deur A, Djalali C, Dupre R, Ehrhart M, El Alaoui A, El Fassi L, Elouadrhiri L, Fegan S, Filippi A, Gavalian G, Glazier DI, Golubenko AA, Gosta G, Gothe RW, Gotra Y, Griffioen K, Hafidi K, Hakobyan H, Hattawy M, Hayward TB, Heddle D, Hobart A, Holtrop M, Illari I, Ireland DG, Isupov EL, Jo HS, Johnston R, Keller D, Khachatryan M, Khanal A, Kim A, Kim W, Klimenko V, Kripko A, Kubarovsky V, Kuhn SE, Lagerquist V, Lanza L, Leali M, Lee S, Lenisa P, Li X, MacGregor IJD, Marchand D, Mascagna V, Matousek G, McKinnon B, McLauchlin C, Meziani ZE, Migliorati S, Milner RG, Mineeva T, Mirazita M, Mokeev V, Moran P, Munoz Camacho C, Naidoo P, Neupane K, Niccolai S, Niculescu G, Osipenko M, Pandey P, Paolone M, Pappalardo LL, Paremuzyan R, Paul SJ, Phelps W, Pilleux N, Pokhrel M, Poudel J, Price JW, Prok Y, Radic A, Raue BA, Reed T, Richards J, Ripani M, Ritman J, Rossi P, Sabatié F, Salgado C, Schadmand S, Schmidt A, Sharabian YG, Shrestha U, Sokhan D, Sparveris N, Spreafico M, Stepanyan S, Strakovsky I, Strauch S, Turisini M, Tyson R, Ungaro M, Vallarino S, Venturelli L, Voskanyan H, Voutier E, Watts DP, Wei X, Williams R, Wishart R, Wood MH, Yurov M, Zachariou N, Zhao ZW, Zurek M. First Measurement of Hard Exclusive π^{-}Δ^{++} Electroproduction Beam-Spin Asymmetries off the Proton. Phys Rev Lett 2023; 131:021901. [PMID: 37505937 DOI: 10.1103/physrevlett.131.021901] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/21/2023] [Revised: 05/22/2023] [Accepted: 06/20/2023] [Indexed: 07/30/2023]
Abstract
The polarized cross-section ratio σ_{LT^{'}}/σ_{0} from hard exclusive π^{-}Δ^{++} electroproduction off an unpolarized hydrogen target has been extracted based on beam-spin asymmetry measurements using a 10.2 GeV/10.6 GeV incident electron beam and the CLAS12 spectrometer at Jefferson Lab. The study, which provides the first observation of this channel in the deep-inelastic regime, focuses on very forward-pion kinematics in the valence regime, and photon virtualities ranging from 1.5 GeV^{2} up to 7 GeV^{2}. The reaction provides a novel access to the d-quark content of the nucleon and to p→Δ^{++} transition generalized parton distributions. A comparison to existing results for hard exclusive π^{+}n and π^{0}p electroproduction is provided, which shows a clear impact of the excitation mechanism, encoded in transition generalized parton distributions, on the asymmetry.
Collapse
Affiliation(s)
- S Diehl
- University of Connecticut, Storrs, Connecticut 06269, USA
- II Physikalisches Institut der Universitaet Giessen, 35392 Giessen, Germany
| | - N Trotta
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - K Joo
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - P Achenbach
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - Z Akbar
- Florida State University, Tallahassee, Florida 32306, USA
- University of Virginia, Charlottesville, Virginia 22901, USA
| | - W R Armstrong
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - H Atac
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - H Avakian
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - L Baashen
- Florida International University, Miami, Florida 33199, USA
| | - N A Baltzell
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - L Barion
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - M Bashkanov
- University of York, York YO10 5DD, United Kingdom
| | | | - I Bedlinskiy
- National Research Centre Kurchatov Institute-TEP, Moscow, 117259, Russia
| | - F Benmokhtar
- Duquesne University, 600 Forbes Avenue, Pittsburgh, Pennsylvania 15282, USA
| | - A Bianconi
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Brescia, 25123 Brescia, Italy
| | - A S Biselli
- Fairfield University, Fairfield Connecticut 06824, USA
| | - F Bossù
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - K-T Brinkmann
- II Physikalisches Institut der Universitaet Giessen, 35392 Giessen, Germany
| | - W J Briscoe
- The George Washington University, Washington, D.C. 20052, USA
| | - D Bulumulla
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - V Burkert
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - R Capobianco
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - D S Carman
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - J C Carvajal
- Florida International University, Miami, Florida 33199, USA
| | - A Celentano
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - G Charles
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - P Chatagnon
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - V Chesnokov
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, 119234 Moscow, Russia
| | - G Ciullo
- Università di Ferrara, 44121 Ferrara, Italy
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - P L Cole
- Lamar University, 4400 MLK Boulevard, P.O. Box 10046, Beaumont, Texas 77710, USA
| | | | - G Costantini
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Brescia, 25123 Brescia, Italy
| | - V Crede
- Florida State University, Tallahassee, Florida 32306, USA
| | - A D'Angelo
- INFN, Sezione di Roma Tor Vergata, 00133 Rome, Italy
- Università di Roma Tor Vergata, 00133 Rome, Italy
| | - N Dashyan
- Yerevan Physics Institute, 375036 Yerevan, Armenia
| | - R De Vita
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - A Deur
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - C Djalali
- Ohio University, Athens, Ohio 45701, USA
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - R Dupre
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - M Ehrhart
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - A El Alaoui
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
| | - L El Fassi
- Mississippi State University, Mississippi State, Mississippi 39762-5167, USA
| | - L Elouadrhiri
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S Fegan
- University of York, York YO10 5DD, United Kingdom
| | - A Filippi
- INFN, Sezione di Torino, 10125 Torino, Italy
| | - G Gavalian
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - D I Glazier
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - A A Golubenko
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, 119234 Moscow, Russia
| | - G Gosta
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Brescia, 25123 Brescia, Italy
| | - R W Gothe
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - Y Gotra
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - K Griffioen
- College of William and Mary, Williamsburg, Virginia 23187-8795, USA
| | - K Hafidi
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - H Hakobyan
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
| | - M Hattawy
- Argonne National Laboratory, Argonne, Illinois 60439, USA
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - T B Hayward
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - D Heddle
- Christopher Newport University, Newport News, Virginia 23606, USA
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - A Hobart
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - M Holtrop
- University of New Hampshire, Durham, New Hampshire 03824-3568, USA
| | - I Illari
- The George Washington University, Washington, D.C. 20052, USA
| | - D G Ireland
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - E L Isupov
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, 119234 Moscow, Russia
| | - H S Jo
- Kyungpook National University, Daegu 41566, Republic of Korea
| | - R Johnston
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307, USA
| | - D Keller
- University of Virginia, Charlottesville, Virginia 22901, USA
| | - M Khachatryan
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - A Khanal
- Florida International University, Miami, Florida 33199, USA
| | - A Kim
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - W Kim
- Kyungpook National University, Daegu 41566, Republic of Korea
| | - V Klimenko
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - A Kripko
- II Physikalisches Institut der Universitaet Giessen, 35392 Giessen, Germany
| | - V Kubarovsky
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S E Kuhn
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - V Lagerquist
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - L Lanza
- INFN, Sezione di Roma Tor Vergata, 00133 Rome, Italy
- Università di Roma Tor Vergata, 00133 Rome, Italy
| | - M Leali
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Brescia, 25123 Brescia, Italy
| | - S Lee
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - P Lenisa
- Università di Ferrara, 44121 Ferrara, Italy
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - X Li
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307, USA
| | | | - D Marchand
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - V Mascagna
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi dell'Insubria, 22100 Como, Italy
- Università degli Studi di Brescia, 25123 Brescia, Italy
| | - G Matousek
- Duke University, Durham, North Carolina 27708-0305, USA
| | - B McKinnon
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - C McLauchlin
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - Z E Meziani
- Argonne National Laboratory, Argonne, Illinois 60439, USA
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - S Migliorati
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Brescia, 25123 Brescia, Italy
| | - R G Milner
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307, USA
| | - T Mineeva
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
| | - M Mirazita
- INFN, Laboratori Nazionali di Frascati, 00044 Frascati, Italy
| | - V Mokeev
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - P Moran
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307, USA
| | - C Munoz Camacho
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - P Naidoo
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - K Neupane
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - S Niccolai
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - G Niculescu
- James Madison University, Harrisonburg, Virginia 22807, USA
| | - M Osipenko
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - P Pandey
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - M Paolone
- New Mexico State University, P.O. Box 30001, Las Cruces, New Mexico 88003, USA
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - L L Pappalardo
- Università di Ferrara, 44121 Ferrara, Italy
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - R Paremuzyan
- University of New Hampshire, Durham, New Hampshire 03824-3568, USA
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S J Paul
- University of California Riverside, 900 University Avenue, Riverside, California 92521, USA
| | - W Phelps
- Christopher Newport University, Newport News, Virginia 23606, USA
- The George Washington University, Washington, D.C. 20052, USA
| | - N Pilleux
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - M Pokhrel
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - J Poudel
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - J W Price
- California State University, Dominguez Hills, Carson, California 90747, USA
| | - Y Prok
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - A Radic
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
| | - B A Raue
- Florida International University, Miami, Florida 33199, USA
| | - T Reed
- Florida International University, Miami, Florida 33199, USA
| | - J Richards
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - M Ripani
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - J Ritman
- GSI Helmholtzzentrum fur Schwerionenforschung GmbH, D-64291 Darmstadt, Germany
- Institute fur Kernphysik (Juelich), Juelich, Germany
| | - P Rossi
- INFN, Laboratori Nazionali di Frascati, 00044 Frascati, Italy
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - F Sabatié
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - C Salgado
- Norfolk State University, Norfolk, Virginia 23504, USA
| | - S Schadmand
- GSI Helmholtzzentrum fur Schwerionenforschung GmbH, D-64291 Darmstadt, Germany
| | - A Schmidt
- The George Washington University, Washington, D.C. 20052, USA
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307, USA
| | - Y G Sharabian
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - U Shrestha
- University of Connecticut, Storrs, Connecticut 06269, USA
- Ohio University, Athens, Ohio 45701, USA
| | - D Sokhan
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - N Sparveris
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - M Spreafico
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - S Stepanyan
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - I Strakovsky
- The George Washington University, Washington, D.C. 20052, USA
| | - S Strauch
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - M Turisini
- INFN, Laboratori Nazionali di Frascati, 00044 Frascati, Italy
| | - R Tyson
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - M Ungaro
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S Vallarino
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - L Venturelli
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Brescia, 25123 Brescia, Italy
| | - H Voskanyan
- Yerevan Physics Institute, 375036 Yerevan, Armenia
| | - E Voutier
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - D P Watts
- University of York, York YO10 5DD, United Kingdom
| | - X Wei
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - R Williams
- University of York, York YO10 5DD, United Kingdom
| | - R Wishart
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - M H Wood
- Canisius College, Buffalo, New York 14208-1517, USA
| | - M Yurov
- Mississippi State University, Mississippi State, Mississippi 39762-5167, USA
| | - N Zachariou
- University of York, York YO10 5DD, United Kingdom
| | - Z W Zhao
- Duke University, Durham, North Carolina 27708-0305, USA
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - M Zurek
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| |
Collapse
|
27
|
Kim W, Woo IH, Eom Y, Song JS. Short-term changes in tear osmolarity after instillation of different osmolarity eye drops in patients with dry eye. Sci Rep 2023; 13:11012. [PMID: 37419888 PMCID: PMC10328951 DOI: 10.1038/s41598-023-35965-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/15/2023] [Accepted: 05/26/2023] [Indexed: 07/09/2023] Open
Abstract
This study investigated short-term changes in tear osmolarity of dry eye patients after using artificial tears containing sodium hyaluronate (SH) at different osmolarities. It comprised 80 patients with dry eye whose tear osmolarity measurement using the TearLab osmolarity system was 300 mOsm/L or greater. Patients who had external ocular disease, glaucoma, or other concomitant ocular pathology were excluded. After being randomly divided into four groups, the participants received different kinds of SH eye drops as follows: Groups 1-3 were given one of three concentrations (0.1%, 0.15%, and 0.3%) of isotonic drops, while Group 4 received 0.18% hypotonic SH eye drops. The tear osmolarity concentrations were evaluated at baseline and again at 1-, 5-, and 10-min after instillation of each eye drop. Tear osmolarity showed a significant decrease after instillation of four types of SH eye drops after up to 10 min compared to baseline. Patients who received hypotonic SH eye drops showed an enhanced decrease in tear osmolarity compared with the isotonic SH eye drops after 1 min (p < 0.001) and 5 min (p = 0.006), but the difference was not significant at 10 min (p = 0.836). The enhanced immediate effect of hypotonic SH eye drops at lowering tear osmolarity in patients with dry eye seems to be limited unless these drops were used frequently.
Collapse
Affiliation(s)
- Woojin Kim
- Department of Ophthalmology, Korea University Guro Hospital, 148, Gurodong-Ro, Guro-Gu, Seoul, Republic of Korea
| | - In Ho Woo
- Department of Ophthalmology, Korea University Guro Hospital, 148, Gurodong-Ro, Guro-Gu, Seoul, Republic of Korea
| | - Youngsub Eom
- Department of Ophthalmology, Korea University Ansan Hospital, 123, Jeokgeum-Ro, Danwon-Gu, Ansan-Si, Gyeonggi-Do, Republic of Korea
| | - Jong Suk Song
- Department of Ophthalmology, Korea University Guro Hospital, 148, Gurodong-Ro, Guro-Gu, Seoul, Republic of Korea.
| |
Collapse
|
28
|
Boudko SP, Konopka EH, Kim W, Taga Y, Mizuno K, Springer TA, Hudson BG, Moy TI, Lin FY. A recombinant technique for mapping functional sites of heterotrimeric collagen helices: Collagen IV CB3 fragment as a prototype for integrin binding. J Biol Chem 2023; 299:104901. [PMID: 37302550 PMCID: PMC10404678 DOI: 10.1016/j.jbc.2023.104901] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/08/2023] [Revised: 06/01/2023] [Accepted: 06/05/2023] [Indexed: 06/13/2023] Open
Abstract
Collagen superfamily of proteins is a major component of the extracellular matrix. Defects in collagens underlie the cause of nearly 40 human genetic diseases in millions of people worldwide. Pathogenesis typically involves genetic alterations of the triple helix, a hallmark structural feature that bestows exceptional mechanical resistance to tensile forces and a capacity to bind a plethora of macromolecules. Yet, there is a paramount knowledge gap in understanding the functionality of distinct sites along the triple helix. Here, we present a recombinant technique to produce triple helical fragments for functional studies. The experimental strategy utilizes the unique capacity of the NC2 heterotrimerization domain of collagen IX to drive three α-chain selection and registering the triple helix stagger. For proof of principle, we produced and characterized long triple helical fragments of collagen IV that were expressed in a mammalian system. The heterotrimeric fragments encompassed the CB3 trimeric peptide of collagen IV, which harbors the binding motifs for α1β1 and α2β1 integrins. Fragments were characterized and shown to have a stable triple helix, post-translational modifications, and high affinity and specific binding of integrins. The NC2 technique is a universal tool for the high-yield production of heterotrimeric fragments of collagens. Fragments are suitable for mapping functional sites, determining coding sequences of binding sites, elucidating pathogenicity and pathogenic mechanisms of genetic mutations, and production of fragments for protein replacement therapy.
Collapse
Affiliation(s)
- Sergei P Boudko
- Division of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA; Center for Matrix Biology, Vanderbilt University Medical Center, Nashville, Tennessee, USA; Department of Biochemistry, Vanderbilt University, Nashville, Tennessee, USA.
| | | | - Woojin Kim
- Morphic Therapeutic, Inc, Waltham, Massachusetts, USA
| | - Yuki Taga
- Nippi Research Institute of Biomatrix, Toride, Ibaraki, Japan
| | - Kazunori Mizuno
- Nippi Research Institute of Biomatrix, Toride, Ibaraki, Japan
| | - Timothy A Springer
- Department of Biological Chemistry and Molecular Pharmacology, Program in Cellular and Molecular Medicine, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA
| | - Billy G Hudson
- Division of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA; Center for Matrix Biology, Vanderbilt University Medical Center, Nashville, Tennessee, USA; Department of Biochemistry, Vanderbilt University, Nashville, Tennessee, USA; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA; Department of Cell and Developmental Biology, Vanderbilt University Medical Center, Nashville, Tennessee, USA; Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee, USA; Vanderbilt Institute of Chemical Biology, Vanderbilt University, Nashville, Tennessee, USA
| | - Terence I Moy
- Morphic Therapeutic, Inc, Waltham, Massachusetts, USA
| | - Fu-Yang Lin
- Morphic Therapeutic, Inc, Waltham, Massachusetts, USA.
| |
Collapse
|
29
|
Han S, Kim W, Kim Y. Feasibility study of MEMS-based stenosis detection using a prototypical catheter design with intravascular scanning probes (IVSPs). Med Eng Phys 2023; 117:104000. [PMID: 37331753 DOI: 10.1016/j.medengphy.2023.104000] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/26/2022] [Revised: 04/26/2023] [Accepted: 05/27/2023] [Indexed: 06/20/2023]
Abstract
X-ray coronary angiography (XRA) is a standard clinical method for diagnosing coronary artery disease (CAD). However, despite continuous improvements in XRA technology, it has limitations that include being visible only in color contrast, and the information it provides on coronary artery plaques is not comprehensive due to its low signal-to-noise ratio and limited resolution. In this study, we propose a novel diagnostic tool, a MEMS-based smart catheter with an intravascular scanning probe (IVSP), to complement XRA and verify its effectiveness and feasibility. The IVSP catheter uses Pt strain gauges embedded on the probe to examine the characteristics of a blood vessel, such as the degree of stenosis and morphological structures of the vessel walls, through physical contact. The feasibility test results showed that the output signals of the IVSP catheter reflected the morphological structure of the phantom glass vessel that mimicked stenosis. In particular, the IVSP catheter successfully assessed the morphology of the stenosis, which was only 17% of the cross-sectional diameter obstructed. In addition, the strain distribution on the probe surface was studied using finite element analysis (FEA), and a correlation between the experimental and FEA results was derived.
Collapse
Affiliation(s)
- Suyong Han
- Finemedix, 140-9, Yuram-ro, Dong-gu, Daegu, 41059, Republic of Korea
| | - Woojin Kim
- Advanced Mechatronics Research Group, Korea Institute of Industrial Technology, Daegu, Republic of Korea
| | - Yongdae Kim
- Kyungil University, 50 Gamasilgil, Hayangeup, Gyeongsan, Gyeongbuk, 38428, Republic of Korea.
| |
Collapse
|
30
|
Kang S, Hong YS, Park J, Kang D, Kim H, Lee J, Kim W, Kang SW, Guallar E, Cho J, Park HY. Air pollution and mortality in patients with chronic obstructive pulmonary disease: a cohort study in South Korea. Ther Adv Chronic Dis 2023; 14:20406223231176175. [PMID: 37324407 PMCID: PMC10265343 DOI: 10.1177/20406223231176175] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/07/2022] [Accepted: 04/28/2023] [Indexed: 06/17/2023] Open
Abstract
Background Evidence on whether long-term exposure to air pollution increases the mortality risk in patients with chronic obstructive pulmonary disease (COPD) is limited. Objectives We aimed to investigate the associations of long-term exposure to particulate matter with diameter <10 µm (PM10) and nitrogen dioxide (NO2) with overall and disease-specific mortality in COPD patients. Design We conducted a nationwide retrospective cohort study of 121,423 adults ⩾40 years diagnosed with COPD during 1 January to 31 December 2009. Methods Exposure to PM10 and NO2 was estimated for residential location using the ordinary kriging method. We estimated the risk of overall mortality associated with 1-, 3-, and 5-years average concentrations of PM10 and NO2 using Cox proportional hazards models and disease-specific mortality using the Fine and Gray method adjusted for age, sex, income, body mass index, smoking, comorbidities, and exacerbation history. Results The adjusted hazard ratios (HRs) for overall mortality associated with a 10 µg/m3 increase in 1-year PM10 and NO2 exposures were 1.004 [95% confidence interval (CI) = 0.985, 1.023] and 0.993 (95% CI = 0.984, 1.002), respectively. The results were similar for 3- and 5-year exposures. For a 10-µg/m3 increase in 1-year PM10 and NO2 exposures, the adjusted HRs for chronic lower airway disease mortality were 1.068 (95% CI = 1.024, 1.113) and 1.029 (95% CI = 1.009, 1.050), respectively. In stratified analyses, exposures to PM10 and NO2 were associated with overall mortality in patients who were underweight and had a history of severe exacerbation. Conclusion In this large population-based study of patients with COPD, long-term PM10 and NO2 exposures were not associated with overall mortality but were associated with chronic lower airway disease mortality. PM10 and NO2 exposures were both associated with an increased risk of overall mortality, and with overall mortality in underweight individuals and those with a history of severe exacerbation.
Collapse
Affiliation(s)
- Suna Kang
- Korea Environment Institute, Sicheong-daero, Sejong, South Korea
- Department of Clinical Research Design and Evaluation, SAIHST, Sungkyunkwan University, Seoul, South Korea
| | - Yun Soo Hong
- Departments of Epidemiology and Medicine, and Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
| | - Jihwan Park
- Departments of Epidemiology and Medicine, and Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
| | - Danbee Kang
- Department of Clinical Research Design and Evaluation, SAIHST, Sungkyunkwan University, Seoul, South Korea
- Center for Clinical Epidemiology, Samsung Medical Center, Seoul, South Korea
| | - Hyunsoo Kim
- Center for Clinical Epidemiology, Samsung Medical Center, Seoul, South Korea
- Department of Digital Health, SAIHST, Sungkyunkwan University, Seoul, South Korea
| | - Jin Lee
- Department of Clinical Research Design and Evaluation, SAIHST, Sungkyunkwan University, Seoul, South Korea
- Center for Clinical Epidemiology, Samsung Medical Center, Seoul, South Korea
| | - Woojin Kim
- Department of Internal Medicine and Environmental Health Center, Kangwon National University Hospital, Kangwon National University School of Medicine, Chuncheon, South Korea
| | | | - Eliseo Guallar
- Departments of Epidemiology and Medicine, and Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
| | - Juhee Cho
- Department of Clinical Research Design and Evaluation, SAIHST, Sungkyunkwan University, 81 Irwon-ro, Gangnam-gu, Seoul 06351, South Korea
- Departments of Epidemiology and Medicine, and Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
- Center for Clinical Epidemiology, Samsung Medical Center, Seoul, South Korea
- Department of Digital Health, SAIHST, Sungkyunkwan University, Seoul, South Korea
| | - Hye Yun Park
- Department of Clinical Research Design and Evaluation, SAIHST, Sungkyunkwan University, Seoul, South Korea
- Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06351, South Korea
| |
Collapse
|
31
|
Christiaens G, Defurne M, Sokhan D, Achenbach P, Akbar Z, Amaryan MJ, Atac H, Avakian H, Gayoso CA, Baashen L, Baltzell NA, Barion L, Bashkanov M, Battaglieri M, Bedlinskiy I, Benkel B, Benmokhtar F, Bianconi A, Biselli AS, Bondi M, Booth WA, Bossù F, Boiarinov S, Brinkmann KT, Briscoe WJ, Bueltmann S, Bulumulla D, Burkert VD, Cao T, Carman DS, Carvajal JC, Celentano A, Chatagnon P, Chesnokov V, Chetry T, Ciullo G, Clash G, Cole PL, Contalbrigo M, Costantini G, D'Angelo A, Dashyan N, De Vita R, Deur A, Diehl S, Dilks C, Djalali C, Dupre R, Egiyan H, Ehrhart M, Alaoui AE, Fassi LE, Elouadrhiri L, Fegan S, Filippi A, Gates K, Gavalian G, Ghandilyan Y, Gilfoyle GP, Girod FX, Glazier DI, Golubenko AA, Gosta G, Gothe RW, Gotra Y, Griffioen KA, Guidal M, Hafidi K, Hakobyan H, Hattawy M, Hauenstein F, Hayward TB, Heddle D, Hobart A, Holmberg DE, Holtrop M, Ilieva Y, Ireland DG, Isupov EL, Jo HS, Keller D, Khachatryan M, Khanal A, Kim W, Kripko A, Kubarovsky V, Kuhn SE, Lagerquist V, Lanza L, Kabir ML, Leali M, Lee S, Lenisa P, Li X, Livingston K, MacGregor IJD, Marchand D, Mascagna V, Matousek G, McKinnon B, McLauchlin C, Meziani ZE, Migliorati S, Milner RG, Mineeva T, Mirazita M, Mokeev V, Molina E, Camacho CM, Nadel-Turonski P, Naidoo P, Neupane K, Niccolai S, Nicol M, Niculescu G, Osipenko M, Ouillon M, Pandey P, Paolone M, Pappalardo LL, Paremuzyan R, Pasyuk E, Paul SJ, Phelps W, Pilleux N, Pokhrel M, Poudel J, Price JW, Prok Y, Radic A, Ramasubramanian N, Raue BA, Reed T, Richards J, Ripani M, Ritman J, Rossi P, Sabatié F, Salgado C, Schadmand S, Schmidt A, Scott MBC, Sharabian YG, Shirokov EV, Shrestha U, Simmerling P, Sparveris N, Spreafico M, Stepanyan S, Strakovsky II, Strauch S, Tan JA, Trotta N, Turisini M, Tyson R, Ungaro M, Vallarino S, Venturelli L, Voskanyan H, Voutier E, Watts DP, Wei X, Williams R, Wishart R, Wood MH, Zachariou N, Zhang J, Zhao ZW, Ziegler V, Zurek M. First CLAS12 Measurement of Deeply Virtual Compton Scattering Beam-Spin Asymmetries in the Extended Valence Region. Phys Rev Lett 2023; 130:211902. [PMID: 37295113 DOI: 10.1103/physrevlett.130.211902] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/05/2022] [Revised: 03/24/2023] [Accepted: 04/21/2023] [Indexed: 06/12/2023]
Abstract
Deeply virtual Compton scattering (DVCS) allows one to probe generalized parton distributions describing the 3D structure of the nucleon. We report the first measurement of the DVCS beam-spin asymmetry using the CLAS12 spectrometer with a 10.2 and 10.6 GeV electron beam scattering from unpolarized protons. The results greatly extend the Q^{2} and Bjorken-x phase space beyond the existing data in the valence region and provide 1600 new data points measured with unprecedented statistical uncertainty, setting new, tight constraints for future phenomenological studies.
Collapse
Affiliation(s)
- G Christiaens
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - M Defurne
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - D Sokhan
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - P Achenbach
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - Z Akbar
- University of Virginia, Charlottesville, Virginia 22901, USA
| | - M J Amaryan
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - H Atac
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - H Avakian
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - C Ayerbe Gayoso
- College of William and Mary, Williamsburg, Virginia 23187-8795, USA
| | - L Baashen
- Florida International University, Miami, Florida 33199, USA
| | - N A Baltzell
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - L Barion
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - M Bashkanov
- University of York, York YO10 5DD, United Kingdom
| | | | - I Bedlinskiy
- National Research Centre Kurchatov Institute-ITEP, Moscow, 117259, Russia
| | - B Benkel
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
| | - F Benmokhtar
- Duquesne University, 600 Forbes Avenue, Pittsburgh, Pennsylvania 15282, USA
| | - A Bianconi
- Universit'a degli Studi di Brescia, 25123 Brescia, Italy
- INFN, Sezione di Pavia, 27100 Pavia, Italy
| | - A S Biselli
- Fairfield University, Fairfield, Connecticut 06824, USA
| | - M Bondi
- INFN, Sezione di Roma Tor Vergata, 00133 Rome, Italy
| | - W A Booth
- University of York, York YO10 5DD, United Kingdom
| | - F Bossù
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - S Boiarinov
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - K-Th Brinkmann
- II Physikalisches Institut der Universitaet Giessen, 35392 Giessen, Germany
| | - W J Briscoe
- The George Washington University, Washington, D.C. 20052, USA
| | - S Bueltmann
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - D Bulumulla
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - V D Burkert
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - T Cao
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - D S Carman
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - J C Carvajal
- Florida International University, Miami, Florida 33199, USA
| | - A Celentano
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - P Chatagnon
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - V Chesnokov
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, 119234 Moscow, Russia
| | - T Chetry
- Florida International University, Miami, Florida 33199, USA
- Mississippi State University, Mississippi State, Mississippi 39762-5167, USA
- Ohio University, Athens, Ohio 45701, USA
| | - G Ciullo
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
- Universita' di Ferrara, 44121 Ferrara, Italy
| | - G Clash
- University of York, York YO10 5DD, United Kingdom
| | - P L Cole
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
- Lamar University, 4400 MLK Boulevard, P.O. Box 10046, Beaumont, Texas 77710, USA
- Catholic University of America, Washington, D.C. 20064, USA
| | | | - G Costantini
- Universit'a degli Studi di Brescia, 25123 Brescia, Italy
- INFN, Sezione di Pavia, 27100 Pavia, Italy
| | - A D'Angelo
- INFN, Sezione di Roma Tor Vergata, 00133 Rome, Italy
- Universita' di Roma Tor Vergata, 00133 Rome, Italy
| | - N Dashyan
- Yerevan Physics Institute, 375036 Yerevan, Armenia
| | - R De Vita
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - A Deur
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S Diehl
- II Physikalisches Institut der Universitaet Giessen, 35392 Giessen, Germany
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - C Dilks
- Duke University, Durham, North Carolina 27708-0305, USA
| | - C Djalali
- Ohio University, Athens, Ohio 45701, USA
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - R Dupre
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - H Egiyan
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - M Ehrhart
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - A El Alaoui
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
| | - L El Fassi
- Mississippi State University, Mississippi State, Mississippi 39762-5167, USA
| | - L Elouadrhiri
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S Fegan
- University of York, York YO10 5DD, United Kingdom
| | - A Filippi
- INFN, Sezione di Torino, 10125 Torino, Italy
| | - K Gates
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - G Gavalian
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - Y Ghandilyan
- Yerevan Physics Institute, 375036 Yerevan, Armenia
| | - G P Gilfoyle
- University of Richmond, Richmond, Virginia 23173, USA
| | - F X Girod
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - D I Glazier
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - A A Golubenko
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, 119234 Moscow, Russia
| | - G Gosta
- Universit'a degli Studi di Brescia, 25123 Brescia, Italy
| | - R W Gothe
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - Y Gotra
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - K A Griffioen
- College of William and Mary, Williamsburg, Virginia 23187-8795, USA
| | - M Guidal
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - K Hafidi
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - H Hakobyan
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
| | - M Hattawy
- Old Dominion University, Norfolk, Virginia 23529, USA
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - F Hauenstein
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - T B Hayward
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - D Heddle
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
- Christopher Newport University, Newport News, Virginia 23606, USA
| | - A Hobart
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - D E Holmberg
- College of William and Mary, Williamsburg, Virginia 23187-8795, USA
| | - M Holtrop
- University of New Hampshire, Durham, New Hampshire 03824-3568, USA
| | - Y Ilieva
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - D G Ireland
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - E L Isupov
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, 119234 Moscow, Russia
| | - H S Jo
- Kyungpook National University, Daegu 41566, Republic of Korea
| | - D Keller
- University of Virginia, Charlottesville, Virginia 22901, USA
| | - M Khachatryan
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - A Khanal
- Florida International University, Miami, Florida 33199, USA
| | - W Kim
- Kyungpook National University, Daegu 41566, Republic of Korea
| | - A Kripko
- II Physikalisches Institut der Universitaet Giessen, 35392 Giessen, Germany
| | - V Kubarovsky
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S E Kuhn
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - V Lagerquist
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - L Lanza
- INFN, Sezione di Roma Tor Vergata, 00133 Rome, Italy
| | - M L Kabir
- Mississippi State University, Mississippi State, Mississippi 39762-5167, USA
| | - M Leali
- Universit'a degli Studi di Brescia, 25123 Brescia, Italy
- INFN, Sezione di Pavia, 27100 Pavia, Italy
| | - S Lee
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307, USA
| | - P Lenisa
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
- Universita' di Ferrara, 44121 Ferrara, Italy
| | - X Li
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307, USA
| | - K Livingston
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | | | - D Marchand
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - V Mascagna
- Universit'a degli Studi di Brescia, 25123 Brescia, Italy
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi dell'Insubria, 22100 Como, Italy
| | - G Matousek
- Duke University, Durham, North Carolina 27708-0305, USA
| | - B McKinnon
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - C McLauchlin
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - Z E Meziani
- Temple University, Philadelphia, Pennsylvania 19122, USA
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - S Migliorati
- Universit'a degli Studi di Brescia, 25123 Brescia, Italy
- INFN, Sezione di Pavia, 27100 Pavia, Italy
| | - R G Milner
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307, USA
| | - T Mineeva
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
| | - M Mirazita
- INFN, Laboratori Nazionali di Frascati, 00044 Frascati, Italy
| | - V Mokeev
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - E Molina
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
| | - C Munoz Camacho
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - P Nadel-Turonski
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - P Naidoo
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - K Neupane
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - S Niccolai
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - M Nicol
- University of York, York YO10 5DD, United Kingdom
| | - G Niculescu
- James Madison University, Harrisonburg, Virginia 22807, USA
| | - M Osipenko
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - M Ouillon
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - P Pandey
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - M Paolone
- Temple University, Philadelphia, Pennsylvania 19122, USA
- New Mexico State University, P.O. Box 30001, Las Cruces, New Mexico 88003, USA
| | - L L Pappalardo
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
- Universita' di Ferrara, 44121 Ferrara, Italy
| | - R Paremuzyan
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
- University of New Hampshire, Durham, New Hampshire 03824-3568, USA
| | - E Pasyuk
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S J Paul
- University of California Riverside, 900 University Avenue, Riverside, California 92521, USA
| | - W Phelps
- The George Washington University, Washington, D.C. 20052, USA
- Christopher Newport University, Newport News, Virginia 23606, USA
| | - N Pilleux
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - M Pokhrel
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - J Poudel
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - J W Price
- California State University, Dominguez Hills, Carson, California 90747, USA
| | - Y Prok
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - A Radic
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
| | | | - B A Raue
- Florida International University, Miami, Florida 33199, USA
| | - Trevor Reed
- Florida International University, Miami, Florida 33199, USA
| | - J Richards
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - M Ripani
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - J Ritman
- GSI Helmholtzzentrum fur Schwerionenforschung GmbH, D 64291 Darmstadt, Germany
- Institute fur Kernphysik (Juelich), 52428 Juelich, Germany
| | - P Rossi
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
- INFN, Laboratori Nazionali di Frascati, 00044 Frascati, Italy
| | - F Sabatié
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - C Salgado
- Norfolk State University, Norfolk, Virginia 23504, USA
| | - S Schadmand
- GSI Helmholtzzentrum fur Schwerionenforschung GmbH, D 64291 Darmstadt, Germany
- Institute fur Kernphysik (Juelich), 52428 Juelich, Germany
| | - A Schmidt
- The George Washington University, Washington, D.C. 20052, USA
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307, USA
| | - M B C Scott
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - Y G Sharabian
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - E V Shirokov
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, 119234 Moscow, Russia
| | - U Shrestha
- Ohio University, Athens, Ohio 45701, USA
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - P Simmerling
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - N Sparveris
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - M Spreafico
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - S Stepanyan
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - I I Strakovsky
- The George Washington University, Washington, D.C. 20052, USA
| | - S Strauch
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - J A Tan
- Kyungpook National University, Daegu 41566, Republic of Korea
| | - N Trotta
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - M Turisini
- INFN, Laboratori Nazionali di Frascati, 00044 Frascati, Italy
| | - R Tyson
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - M Ungaro
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S Vallarino
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - L Venturelli
- Universit'a degli Studi di Brescia, 25123 Brescia, Italy
- INFN, Sezione di Pavia, 27100 Pavia, Italy
| | - H Voskanyan
- Yerevan Physics Institute, 375036 Yerevan, Armenia
| | - E Voutier
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - D P Watts
- University of York, York YO10 5DD, United Kingdom
| | - X Wei
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - R Williams
- University of York, York YO10 5DD, United Kingdom
| | - R Wishart
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - M H Wood
- Canisius College, Buffalo, New York 14208, USA
| | - N Zachariou
- University of York, York YO10 5DD, United Kingdom
| | - J Zhang
- University of Virginia, Charlottesville, Virginia 22901, USA
| | - Z W Zhao
- Old Dominion University, Norfolk, Virginia 23529, USA
- Duke University, Durham, North Carolina 27708-0305, USA
| | - V Ziegler
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - M Zurek
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| |
Collapse
|
32
|
Nam S, Lee S, Kim W, Kim I. Divergent synthesis of two types of indolizines from pyridine-2-acetonitrile, (hetero)arylglyoxal, and TMSCN. Org Biomol Chem 2023; 21:3881-3895. [PMID: 37097478 DOI: 10.1039/d3ob00471f] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/26/2023]
Abstract
Herein we describe the divergent synthesis of two types of indolizines via construction of the pyrrole moiety from pyridine-2-acetonitriles, arylglyoxals, and TMSCN. While one-pot three-component coupling provided 2-aryl-3-aminoindolizines via an unusual fragmentation process, a sequential two-step assembly protocol with these starting materials allowed efficient access to a wide range of new 2-acyl-3-aminoindolizines through an aldol condensation-Michael addition-cycloisomerization process. The subsequent manipulation of 2-acyl-3-aminoindolizines enabled direct access to novel polycyclic N-fused heteroaromatic skeletons.
Collapse
Affiliation(s)
- Seonghyeon Nam
- College of Pharmacy and Yonsei Institute of Pharmaceutical Sciences, Yonsei University, 85 Songdogwahak-ro, Yeonsu-gu, Incheon, 21983, Republic of Korea.
| | - Sunhee Lee
- College of Pharmacy and Yonsei Institute of Pharmaceutical Sciences, Yonsei University, 85 Songdogwahak-ro, Yeonsu-gu, Incheon, 21983, Republic of Korea.
| | - Woojin Kim
- College of Pharmacy and Yonsei Institute of Pharmaceutical Sciences, Yonsei University, 85 Songdogwahak-ro, Yeonsu-gu, Incheon, 21983, Republic of Korea.
| | - Ikyon Kim
- College of Pharmacy and Yonsei Institute of Pharmaceutical Sciences, Yonsei University, 85 Songdogwahak-ro, Yeonsu-gu, Incheon, 21983, Republic of Korea.
| |
Collapse
|
33
|
Chetry T, El Fassi L, Brooks WK, Dupré R, El Alaoui A, Hafidi K, Achenbach P, Adhikari KP, Akbar Z, Armstrong WR, Arratia M, Atac H, Avakian H, Baashen L, Baltzell NA, Barion L, Bashkanov M, Battaglieri M, Bedlinskiy I, Benkel B, Benmokhtar F, Bianconi A, Biselli AS, Bondi M, Booth WA, Bossù F, Boiarinov S, Brinkmann KT, Briscoe WJ, Bulumulla D, Burkert VD, Carman DS, Carvajal JC, Celentano A, Chatagnon P, Chesnokov V, Ciullo G, Cole PL, Contalbrigo M, Costantini G, D'Angelo A, Dashyan N, De Vita R, Defurne M, Deur A, Diehl S, Djalali C, Egiyan H, Elouadrhiri L, Eugenio P, Fegan S, Filippi A, Gavalian G, Ghandilyan Y, Gilfoyle GP, Glazier DI, Golubenko AA, Gosta G, Gothe RW, Griffioen KA, Guidal M, Guo L, Hakobyan H, Hattawy M, Hayward TB, Heddle D, Hobart A, Holtrop M, Ilieva Y, Ireland DG, Isupov EL, Jenkins D, Jo HS, Kabir ML, Khanal A, Khandaker M, Kim A, Kim W, Klein FJ, Kripko A, Kubarovsky V, Lagerquist V, Lanza L, Leali M, Lee S, Lenisa P, Li X, Livingston K, MacGregor IJD, Marchand D, Mascagna V, McKinnon B, McLauchlin C, Meziani ZE, Migliorati S, Mineeva T, Mirazita M, Mokeev V, Munoz Camacho C, Nadel-Turonski P, Neupane K, Niccolai S, Nicol M, Niculescu G, Osipenko M, Ostrovidov AI, Pandey P, Paolone M, Pappalardo LL, Paremuzyan R, Pasyuk E, Paul SJ, Phelps W, Pilleux N, Pokhrel M, Poudel J, Price JW, Prok Y, Raue BA, Reed T, Richards J, Ripani M, Ritman J, Rosner G, Sabatié F, Salgado C, Schadmand S, Schmidt A, Schumacher RA, Sharabian YG, Shirokov EV, Shrestha U, Simmerling P, Sokhan D, Sparveris N, Stepanyan S, Strakovsky II, Strauch S, Tan JA, Trotta N, Tyson R, Ungaro M, Vallarino S, Venturelli L, Voskanyan H, Voutier E, Wei X, Weinstein LB, Williams R, Wishart R, Wood MH, Yurov M, Zachariou N, Zhao ZW, Zurek M. First Measurement of Λ Electroproduction off Nuclei in the Current and Target Fragmentation Regions. Phys Rev Lett 2023; 130:142301. [PMID: 37084423 DOI: 10.1103/physrevlett.130.142301] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/26/2022] [Revised: 02/01/2023] [Accepted: 02/24/2023] [Indexed: 05/03/2023]
Abstract
We report results of Λ hyperon production in semi-inclusive deep-inelastic scattering off deuterium, carbon, iron, and lead targets obtained with the CLAS detector and the Continuous Electron Beam Accelerator Facility 5.014 GeV electron beam. These results represent the first measurements of the Λ multiplicity ratio and transverse momentum broadening as a function of the energy fraction (z) in the current and target fragmentation regions. The multiplicity ratio exhibits a strong suppression at high z and an enhancement at low z. The measured transverse momentum broadening is an order of magnitude greater than that seen for light mesons. This indicates that the propagating entity interacts very strongly with the nuclear medium, which suggests that propagation of diquark configurations in the nuclear medium takes place at least part of the time, even at high z. The trends of these results are qualitatively described by the Giessen Boltzmann-Uehling-Uhlenbeck transport model, particularly for the multiplicity ratios. These observations will potentially open a new era of studies of the structure of the nucleon as well as of strange baryons.
Collapse
Affiliation(s)
- T Chetry
- Florida International University, Miami, Florida 33199, USA
- Mississippi State University, Mississippi State, Mississippi 39762-5167, USA
| | - L El Fassi
- Mississippi State University, Mississippi State, Mississippi 39762-5167, USA
| | - W K Brooks
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
- Universidad Técnica Federico Santa María, Casilla, 110-V Valparaíso, Chile
- Center for Science and Technology of Valparaíso, 699 Valparaíso, Chile
- SAPHIR Millennium Science Institute, Santiago, Chile
| | - R Dupré
- Universit'e Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - A El Alaoui
- Universidad Técnica Federico Santa María, Casilla, 110-V Valparaíso, Chile
| | - K Hafidi
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - P Achenbach
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - K P Adhikari
- Mississippi State University, Mississippi State, Mississippi 39762-5167, USA
| | - Z Akbar
- University of Virginia, Charlottesville, Virginia 22901, USA
| | - W R Armstrong
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - M Arratia
- University of California Riverside, 900 University Avenue, Riverside, California 92521, USA
| | - H Atac
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - H Avakian
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - L Baashen
- Florida International University, Miami, Florida 33199, USA
| | - N A Baltzell
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - L Barion
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - M Bashkanov
- University of York, York YO10 5DD, United Kingdom
| | | | - I Bedlinskiy
- National Research Centre Kurchatov Institute - ITEP, Moscow 117259, Russia
| | - B Benkel
- Universidad Técnica Federico Santa María, Casilla, 110-V Valparaíso, Chile
| | - F Benmokhtar
- Duquesne University, 600 Forbes Avenue, Pittsburgh, Pennsylvania 15282, USA
| | - A Bianconi
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Universit'a degli Studi di Brescia, 25123 Brescia, Italy
| | - A S Biselli
- Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA
- Fairfield University, Fairfield, Connecticut 06824, USA
| | - M Bondi
- INFN, Sezione di Roma Tor Vergata, 00133 Rome, Italy
| | - W A Booth
- University of York, York YO10 5DD, United Kingdom
| | - F Bossù
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - S Boiarinov
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - K-Th Brinkmann
- II Physikalisches Institut der Universitaet Giessen, 35392 Giessen, Germany
| | - W J Briscoe
- The George Washington University, Washington, D.C. 20052, USA
| | - D Bulumulla
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - V D Burkert
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - D S Carman
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - J C Carvajal
- Florida International University, Miami, Florida 33199, USA
| | - A Celentano
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - P Chatagnon
- Universit'e Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - V Chesnokov
- Ohio University, Athens, Ohio 45701, USA
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, 119234 Moscow, Russia
| | - G Ciullo
- Universita' di Ferrara, 44121 Ferrara, Italy
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - P L Cole
- Catholic University of America, Washington, D.C. 20064, USA
- Lamar University, 4400 MLK Boulevard, P.O. Box 10046, Beaumont, Texas 77710, USA
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | | | - G Costantini
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Universit'a degli Studi di Brescia, 25123 Brescia, Italy
| | - A D'Angelo
- INFN, Sezione di Roma Tor Vergata, 00133 Rome, Italy
- Universita' di Roma Tor Vergata, 00133 Rome, Italy
| | - N Dashyan
- Yerevan Physics Institute, 375036 Yerevan, Armenia
| | - R De Vita
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - M Defurne
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - A Deur
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S Diehl
- University of Connecticut, Storrs, Connecticut 06269, USA
- II Physikalisches Institut der Universitaet Giessen, 35392 Giessen, Germany
| | - C Djalali
- Ohio University, Athens, Ohio 45701, USA
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - H Egiyan
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - L Elouadrhiri
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - P Eugenio
- Florida State University, Tallahassee, Florida 32306, USA
| | - S Fegan
- University of York, York YO10 5DD, United Kingdom
| | - A Filippi
- INFN, Sezione di Torino, 10125 Torino, Italy
| | - G Gavalian
- University of New Hampshire, Durham, New Hampshire 03824-3568, USA
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - Y Ghandilyan
- Yerevan Physics Institute, 375036 Yerevan, Armenia
| | - G P Gilfoyle
- University of Richmond, Richmond, Virginia 23173, USA
| | - D I Glazier
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - A A Golubenko
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, 119234 Moscow, Russia
| | - G Gosta
- Universit'a degli Studi di Brescia, 25123 Brescia, Italy
| | - R W Gothe
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - K A Griffioen
- College of William and Mary, Williamsburg, Virginia 23187-8795, USA
| | - M Guidal
- Universit'e Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - L Guo
- Florida International University, Miami, Florida 33199, USA
| | - H Hakobyan
- Universidad Técnica Federico Santa María, Casilla, 110-V Valparaíso, Chile
| | - M Hattawy
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - T B Hayward
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - D Heddle
- Christopher Newport University, Newport News, Virginia 23606, USA
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - A Hobart
- Universit'e Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - M Holtrop
- University of New Hampshire, Durham, New Hampshire 03824-3568, USA
| | - Y Ilieva
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - D G Ireland
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - E L Isupov
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, 119234 Moscow, Russia
| | - D Jenkins
- Virginia Tech, Blacksburg, Virginia 24061-0435, USA
| | - H S Jo
- Kyungpook National University, Daegu 41566, Republic of Korea
| | - M L Kabir
- Mississippi State University, Mississippi State, Mississippi 39762-5167, USA
| | - A Khanal
- Florida International University, Miami, Florida 33199, USA
| | - M Khandaker
- Norfolk State University, Norfolk, Virginia 23504, USA
| | - A Kim
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - W Kim
- Kyungpook National University, Daegu 41566, Republic of Korea
| | - F J Klein
- Catholic University of America, Washington, D.C. 20064, USA
| | - A Kripko
- II Physikalisches Institut der Universitaet Giessen, 35392 Giessen, Germany
| | - V Kubarovsky
- Rensselaer Polytechnic Institute, Troy, New York 12180-3590, USA
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - V Lagerquist
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - L Lanza
- INFN, Sezione di Roma Tor Vergata, 00133 Rome, Italy
| | - M Leali
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Universit'a degli Studi di Brescia, 25123 Brescia, Italy
| | - S Lee
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - P Lenisa
- Universita' di Ferrara, 44121 Ferrara, Italy
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - X Li
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307, USA
| | - K Livingston
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | | | - D Marchand
- Universit'e Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - V Mascagna
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Universit'a degli Studi di Brescia, 25123 Brescia, Italy
| | - B McKinnon
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - C McLauchlin
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - Z E Meziani
- Argonne National Laboratory, Argonne, Illinois 60439, USA
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - S Migliorati
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Universit'a degli Studi di Brescia, 25123 Brescia, Italy
| | - T Mineeva
- Universidad Técnica Federico Santa María, Casilla, 110-V Valparaíso, Chile
| | - M Mirazita
- INFN, Laboratori Nazionali di Frascati, 00044 Frascati, Italy
| | - V Mokeev
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - C Munoz Camacho
- Universit'e Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - P Nadel-Turonski
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - K Neupane
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - S Niccolai
- Universit'e Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - M Nicol
- University of York, York YO10 5DD, United Kingdom
| | - G Niculescu
- James Madison University, Harrisonburg, Virginia 22807, USA
| | - M Osipenko
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - A I Ostrovidov
- Florida State University, Tallahassee, Florida 32306, USA
| | - P Pandey
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - M Paolone
- New Mexico State University, P.O. Box 30001, Las Cruces, New Mexico 88003, USA
| | - L L Pappalardo
- Universita' di Ferrara, 44121 Ferrara, Italy
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - R Paremuzyan
- University of New Hampshire, Durham, New Hampshire 03824-3568, USA
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - E Pasyuk
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S J Paul
- University of California Riverside, 900 University Avenue, Riverside, California 92521, USA
| | - W Phelps
- Christopher Newport University, Newport News, Virginia 23606, USA
- The George Washington University, Washington, D.C. 20052, USA
| | - N Pilleux
- Universit'e Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - M Pokhrel
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - J Poudel
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - J W Price
- California State University, Dominguez Hills, Carson, California 90747, USA
| | - Y Prok
- Old Dominion University, Norfolk, Virginia 23529, USA
- University of Virginia, Charlottesville, Virginia 22901, USA
| | - B A Raue
- Florida International University, Miami, Florida 33199, USA
| | - T Reed
- Florida International University, Miami, Florida 33199, USA
| | - J Richards
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - M Ripani
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - J Ritman
- GSI Helmholtzzentrum fur Schwerionenforschung GmbH, D-64291 Darmstadt, Germany
- Institut fur Kernphysik (Juelich), Juelich 52428, Germany
| | - G Rosner
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - F Sabatié
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - C Salgado
- Norfolk State University, Norfolk, Virginia 23504, USA
| | - S Schadmand
- GSI Helmholtzzentrum fur Schwerionenforschung GmbH, D-64291 Darmstadt, Germany
| | - A Schmidt
- The George Washington University, Washington, D.C. 20052, USA
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307, USA
| | - R A Schumacher
- Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA
| | - Y G Sharabian
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - E V Shirokov
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, 119234 Moscow, Russia
| | - U Shrestha
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - P Simmerling
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - D Sokhan
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - N Sparveris
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - S Stepanyan
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - I I Strakovsky
- The George Washington University, Washington, D.C. 20052, USA
| | - S Strauch
- The George Washington University, Washington, D.C. 20052, USA
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - J A Tan
- Kyungpook National University, Daegu 41566, Republic of Korea
| | - N Trotta
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - R Tyson
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - M Ungaro
- Rensselaer Polytechnic Institute, Troy, New York 12180-3590, USA
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S Vallarino
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - L Venturelli
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Universit'a degli Studi di Brescia, 25123 Brescia, Italy
| | - H Voskanyan
- Yerevan Physics Institute, 375036 Yerevan, Armenia
| | - E Voutier
- Universit'e Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - X Wei
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - L B Weinstein
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - R Williams
- University of York, York YO10 5DD, United Kingdom
| | - R Wishart
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - M H Wood
- Canisius College, Buffalo, New York 14208, USA
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - M Yurov
- Mississippi State University, Mississippi State, Mississippi 39762-5167, USA
| | - N Zachariou
- University of York, York YO10 5DD, United Kingdom
| | - Z W Zhao
- Duke University, Durham, North Carolina 27708-0305, USA
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - M Zurek
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| |
Collapse
|
34
|
Gu EY, Jung J, Back SM, Lim KH, Kim W, Min BS, Han KH, Kim SK, Kim YB. Evaluation of genotoxicity and 13-week subchronic toxicity of root of Asarum heterotropoides var. seoulense (Nakai) Kitag. J Ethnopharmacol 2023; 305:116012. [PMID: 36567041 DOI: 10.1016/j.jep.2022.116012] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/18/2022] [Revised: 11/22/2022] [Accepted: 12/02/2022] [Indexed: 06/17/2023]
Abstract
ETHNOPHARMACOLOGICAL RELEVANCE Asarum heterotropoides var. seoulense (Nakai) Kitag is a traditional herbal medicine used in Korea and China. It is effective in aphthous stomatitis, local anesthesia, headache, toothache, gingivitis, and inflammatory diseases. However, information on the toxicity of the root of Asarum heterotropoides var. seoulense (Nakai) Kitag (AR) is limited. Therefore, preclinical toxicity studies on AR are needed to reduce the risk of excessive intake. AIM OF THE STUDY We aimed to evaluate genotoxicity and the potential toxicity due to repeated administration of AR powder. MATERIALS AND METHODS In vitro bacterial reverse mutation assay (Ames), in vitro chromosomal aberration assay (CA), and in vivo micronucleus (MN) assay in ICR mice were conducted. As positive results were obtained in Ames and CA assays, alkaline comet assay and pig-a gene mutation test were conducted for confirmation. For evaluating the general toxicity of AR powder, a 13-week subchronic toxicity test was conducted, after determining the dose by performing a single and a 4-week dose range finding (DRF) test. A total of 152 Sprague-Dawley (SD) rats were orally administered AR powder at doses of 0, 150, 350, 500, 1000, and 2000 mg/kg/day in the 13-week subchronic toxicity test. Hematology, clinical chemistry, urinalysis, organ weight, macro-, and microscopic examination were conducted after rat necropsy. RESULTS AR powder induced genotoxicity evidenced in the Ames test at 187.5, 750, 375, and 1500 μg/plate of TA100, TA98, TA1537, and E. coli WP2uvrA in the presence and absence of S9, respectively; CA test at 790 μg/mL for 6 h in the presence of S-9; 75 μg/mL for 6 h in the absence of S-9, and 70 μg/mL for 22 h in the absence of S-9 in the stomach in the comet assay but not in MN and pig-a assays. In the 13-week subchronic toxicity study, clinical signs including irregular respiration, noisy respiration, salivation, and decreased body weight or food consumption were observed in males and females in the 2000 mg/kg/day group. In hematology tests, clinical chemistry, urinalysis, organ weight, and macroscopic examination, changes were observed in the dose groups of 500 mg/kg/day and above. Microscopic examination revealed hyperplasia of the stomach as a test-related change. Hepatocellular adenoma and changes in liver-related clinical chemistry parameters were observed. The rat No Observed Adverse Effect Level (NOAEL) was 150 mg/kg/day in males and <150 mg/kg/day in females. CONCLUSIONS AR powder is potentially toxic to the liver and stomach and should be used with caution in humans. A long-term study on carcinogenicity is necessitated because DNA damage or changes in tissue lesions were observed in SD rats.
Collapse
Affiliation(s)
- Eun-Young Gu
- College of Pharmacy, Chung-Nam National University, 99 Daehak-ro, Yuseong-gu, Daejeon, 34134, Republic of Korea; Department of Advanced Toxicology Research, Korea Institute of Toxicology, 141 Gajeong-ro, Yuseong-gu, Daejeon, 34114, Republic of Korea.
| | - Jina Jung
- Department of Advanced Toxicology Research, Korea Institute of Toxicology, 141 Gajeong-ro, Yuseong-gu, Daejeon, 34114, Republic of Korea.
| | - Seng-Min Back
- Department of Advanced Toxicology Research, Korea Institute of Toxicology, 141 Gajeong-ro, Yuseong-gu, Daejeon, 34114, Republic of Korea.
| | - Kwang-Hyun Lim
- Department of Advanced Toxicology Research, Korea Institute of Toxicology, 141 Gajeong-ro, Yuseong-gu, Daejeon, 34114, Republic of Korea.
| | - Woojin Kim
- Department of Advanced Toxicology Research, Korea Institute of Toxicology, 141 Gajeong-ro, Yuseong-gu, Daejeon, 34114, Republic of Korea.
| | - Byung Sun Min
- College of Pharmacy, Daegu Catholic University, Gyeongsan, Gyeongbuk, 38430, Republic of Korea.
| | - Kang-Hyun Han
- Department of Advanced Toxicology Research, Korea Institute of Toxicology, 141 Gajeong-ro, Yuseong-gu, Daejeon, 34114, Republic of Korea.
| | - Sang Kyum Kim
- College of Pharmacy, Chung-Nam National University, 99 Daehak-ro, Yuseong-gu, Daejeon, 34134, Republic of Korea.
| | - Yong-Bum Kim
- Department of Advanced Toxicology Research, Korea Institute of Toxicology, 141 Gajeong-ro, Yuseong-gu, Daejeon, 34114, Republic of Korea.
| |
Collapse
|
35
|
Lim J, Kim W, Kim I, Lee E. Effects of Visual Communication Design Accessibility (VCDA) Guidelines for Low Vision on Public and Open Government Health Data. Healthcare (Basel) 2023; 11:healthcare11071047. [PMID: 37046973 PMCID: PMC10094713 DOI: 10.3390/healthcare11071047] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/09/2023] [Revised: 03/28/2023] [Accepted: 04/01/2023] [Indexed: 04/14/2023] Open
Abstract
Since 2019, the Korean government's investments in making data more accessible to the public have grown by 337%. However, open government data, which should be accessible to everyone, are not entirely accessible to people with low vision, who represent an information-vulnerable class. Emergencies, such as the COVID-19 pandemic, decrease face-to-face encounters and inevitably increase untact encounters. Thus, the information gap experienced by low-vision people, who are underprivileged in terms of information, will be further widened, and they may consequently face various disadvantages. This study proposed visual communication design accessibility (VCDA) guidelines for people with low vision. Introduced screens enhanced by accessibility guidelines were presented to 16 people with low vision and 16 people with normal vision and the speed of visual information recognition was analyzed. No statistically significant difference (p > 0.05) was found due to the small sample size; however, this study's results approached significance with improved visual recognition speed for people with low vision after adopting VCDA. As a result of the intervention, the visual information recognition speed of both normal and low-vision people improved. Thus, our results can help improve information recognition speed among people with normal and low vision.
Collapse
Affiliation(s)
- Jongho Lim
- School of Computer Science & Engineering, College of IT Engineering, Kyungpook National University, Daegu 41566, Republic of Korea
| | - Woojin Kim
- School of Computer Science & Engineering, College of IT Engineering, Kyungpook National University, Daegu 41566, Republic of Korea
| | - Ilkon Kim
- School of Computer Science & Engineering, College of IT Engineering, Kyungpook National University, Daegu 41566, Republic of Korea
| | - Eunjoo Lee
- School of Computer Science & Engineering, College of IT Engineering, Kyungpook National University, Daegu 41566, Republic of Korea
| |
Collapse
|
36
|
Bang MJ, Park S, Kim W, Lee S, Seo JM. Prevalence And Clinical Significance Of Sarcopenia During Treatment Of Abdominal Neuroblastoma In Children. Clin Nutr ESPEN 2023. [DOI: 10.1016/j.clnesp.2022.09.111] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/28/2023]
|
37
|
Kim W, Kim E, Lee J, Song CH, Jung W, Shin S, Kim KB, Shin BS, Kim TH. Development of an LC-MS/MS Assay and Toxicokinetic Characterization of Hexamethylenetetramine in Rats. Toxics 2023; 11:337. [PMID: 37112564 PMCID: PMC10146139 DOI: 10.3390/toxics11040337] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 02/02/2023] [Revised: 03/21/2023] [Accepted: 03/30/2023] [Indexed: 06/19/2023]
Abstract
Hexamethylenetetramine, an aldehyde-releasing agent, is used as a preservative in various food, cosmetics, and medical treatments, such as a treatment for urinary tract infections. It has been reported to be allergenic on contact with the skin, with the additional possibility of causing toxicity once absorbed systemically. Despite its potential toxicity, there are no reports on the in vivo bioavailability of hexamethylenetetramine following oral or dermal administration. In this study, we developed a new simple and sensitive LC-MS/MS method for the determination of hexamethylenetetramine in plasma and applied this method to characterize the toxicokinetics. The developed assay had a sufficient specificity and sensitivity for toxicokinetic characterization, and its accuracy and precision were verified. Following iv injection, the plasma concentration of hexamethylenetetramine showed mono exponential decay, with an elimination half-life of about 1.3 h. Following oral administration, the Tmax reached an average of 0.47 h and bioavailability was estimated as 89.93%. After percutaneous administration, it reached Cmax on average at 2.9-3.6 h. Although the absorption rate was relatively slow, its average bioavailability was calculated as 77.19-78.91%. Overall, most of the orally and percutaneously administered hexamethylenetetramine was absorbed into systemic circulation. The derived results in this study are expected to be utilized as the scientific evidence for further toxicokinetic study and risk assessment.
Collapse
Affiliation(s)
- Woojin Kim
- College of Pharmacy, Daegu Catholic University, Gyeongsan 38430, Republic of Korea
| | - Eunbin Kim
- College of Pharmacy, Daegu Catholic University, Gyeongsan 38430, Republic of Korea
| | - Jaewoong Lee
- College of Pharmacy, Daegu Catholic University, Gyeongsan 38430, Republic of Korea
| | - Chang Ho Song
- School of Pharmacy, Sungkyunkwan University, Suwon 16419, Republic of Korea
| | - Woohyung Jung
- College of Pharmacy, Daegu Catholic University, Gyeongsan 38430, Republic of Korea
| | - Soyoung Shin
- College of Pharmacy, Wonkwang University, Iksan 54538, Republic of Korea
| | - Kyu-Bong Kim
- College of Pharmacy, Dankook University, Cheonan 31116, Republic of Korea
| | - Beom Soo Shin
- School of Pharmacy, Sungkyunkwan University, Suwon 16419, Republic of Korea
| | - Tae Hwan Kim
- College of Pharmacy, Daegu Catholic University, Gyeongsan 38430, Republic of Korea
| |
Collapse
|
38
|
Kim HS, Kim W, Endo I, Jang JY, Kim H, Song KB, Hwang DW, Kang CM, Hwang HK, Park SJ, Han SS, Yoon YS, Do Yang J, Amano R, Yamazoe S, Yanagimoto H, Ajiki T, Ohtsuka M, Suzuki D, Lee DS, Kitahata Y, Amaya K, Sakata J, Seo HI, Yamauchi J, Yabushita Y, Tanaka T, Sakurai N, Hirashita T, Horiguchi A, Unno M, Do You D, Yamashita YI, Kobayashi S, Kyoden Y, Ide T, Nagano H, Nakamura M, Yamaue H, Yamamoto M, Park JS. Proposal of nomograms to predict clinical outcomes in patients with ampulla of Vater cancer based on the Korea-Japan collaborative study. J Hepatobiliary Pancreat Sci 2023; 30:360-373. [PMID: 35996868 DOI: 10.1002/jhbp.1229] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/31/2022] [Revised: 08/02/2022] [Accepted: 08/04/2022] [Indexed: 11/10/2022]
Abstract
BACKGROUND In this study, we aimed to develop and validate a nomogram to predict overall survival (OS) and recurrence-free survival (RFS) in patients who underwent curative resection of ampulla of Vater (AOV) cancer. This is the first study for nomograms in AOV cancer patients using retrospective data based on an international multicenter study. METHODS A total of 2007 patients with AOV adenocarcinoma who received operative therapy between 2002 January and 2015 December in Korea and Japan were retrospectively assessed to develop a prediction model. Nomograms for 5-year OS and 3-year RFS were constructed by dividing the patients who received and who did not receive adjuvant therapy after surgery, respectively. Significant risk factors were identified by univariate and multivariate Cox analyses. Performance assessment of the four prediction models was conducted by the Harrell's concordance index (C-index) and calibration curves using bootstrapping. RESULTS A total of 2007 and 1873 patients were collected for nomogram construction to predict 5-year OS and 3-year RFS. We developed four types of nomograms, including models for 5-year OS and 3-year RFS in patients who did not receive postoperative adjuvant therapy, and 5-year OS and 3-year RFS in patients who received postoperative adjuvant therapy. The C-indices of these nomograms were 0.795 (95% confidence interval [CI]: 0.766-0.823), 0.712 (95% CI: 0.674-0.750), 0.804 (95% CI: 0.7778-0.829), and 0.703 (95% CI: 0.669-0.737), respectively. CONCLUSIONS This predictive model could help clinicians to choose optimal treatment and precisely predict prognosis in AOV cancer patients.
Collapse
Affiliation(s)
- Hyung Sun Kim
- Pancreatobiliary Cancer Clinic, Department of Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea
| | - Woojin Kim
- Department of Preventive medicine, Yonsei University College of Medicine, Seoul, South Korea
| | - Itaru Endo
- Department of Gastroenterological Surgery, Yokohama City University School of Medicine, Yokohama, Japan
| | - Jin-Young Jang
- Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea
| | - Hongbeom Kim
- Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea
| | - Ki Byung Song
- Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
| | - Dae Wook Hwang
- Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
| | - Chang Moo Kang
- Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea
| | - Ho Kyoung Hwang
- Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea
| | - Sang-Jae Park
- Center for Liver and Pancreatobiliary cancer, National Cancer Center, Seoul, South Korea
| | - Sung-Sik Han
- Center for Liver and Pancreatobiliary cancer, National Cancer Center, Seoul, South Korea
| | - Yoo-Seok Yoon
- Seoul National University Bundang Hospital, Seoul National University College of Medicine, Goyang, South Korea
| | - Jae Do Yang
- Department of Surgery, Jeonbuk National University hospital, Jeonju, South Korea
| | - Ryosuke Amano
- Department of Hepato-Biliary-Pancreatic surgery, Osaka City University Graduate School of Medicine, Osaka, Japan
| | - Sadaaki Yamazoe
- Department of Hepato-Biliary-Pancreatic surgery, Osaka City University Graduate School of Medicine, Osaka, Japan
| | - Hiroaki Yanagimoto
- Department of Surgery, Division of Hepato-Biliary-Pancreatic Surgery, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Tetsuo Ajiki
- Department of Surgery, Division of Hepato-Biliary-Pancreatic Surgery, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Masayuki Ohtsuka
- Department of General Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan
| | - Daisuke Suzuki
- Department of General Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan
| | - Dong-Shik Lee
- Department of Surgery, Yeungnam University College of Medicine, Daegu, South Korea
| | - Yuji Kitahata
- 2nd Department of Surgery, Wakayama medical university, Wakayama, Japan
| | - Koji Amaya
- Department of Surgery, Toyama Prefectural Central Hospital, Toyama, Japan
| | - Jun Sakata
- Division of Digestive and General Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan
| | - Hyung Il Seo
- Department of Surgery, Biomedical Research Institute, Pusan National University School of Medicine, Pusan National University Hospital, Busan, South Korea
| | | | - Yasuhiro Yabushita
- Department of Gastroenterological Surgery, Yokohama City University School of Medicine, Yokohama, Japan
| | - Takayuki Tanaka
- Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan
| | - Naoki Sakurai
- Department of Surgery, Yamagata Prefectural Central Hospital, Yamagata, Japan
| | - Teijiro Hirashita
- Department of Gastroenterological and Pediatric Surgery, 48 Oita University Faculty of Medicine, Yufu, Japan
| | - Akihiko Horiguchi
- Department of Gastroenterological Surgery, Fujita Health University Bantane Hospital, Fujita, Japan
| | - Michiaki Unno
- Department of Surgery, Graduate School of Medicine, Tohoku University, Sendai, Japan
| | - Dong Do You
- Department of Surgery, St. Vincent's Hospital, College of Medicine, The Catholic University, Suwon, South Korea
| | - Yo-Ichi Yamashita
- Department of Gastroenterological Surgery, Kumamoto University, Kumamoto, Japan
| | - Shogo Kobayashi
- Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Suita, Japan
| | - Yusuke Kyoden
- Ibaraki Cancer Center, Ibaraki Prefectural Central Hospital, Ibaraki, Japan
| | - Takao Ide
- Department of Surgery, Saga University Faculty of Medicine, Saga, Japan
| | - Hiroaki Nagano
- Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Ube, Japan
| | - Masafumi Nakamura
- Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Kyushu, Japan
| | - Hiroki Yamaue
- 2nd Department of Surgery, Wakayama medical university, Wakayama, Japan
| | - Masakazu Yamamoto
- Department of Surgery, Utsunomiya Memorial Hospital, Utsunomiya, Japan
| | - Joon Seong Park
- Pancreatobiliary Cancer Clinic, Department of Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea
| |
Collapse
|
39
|
Komarraju A, Maxwell C, Kung JW, Mhuircheartaigh JN, Kim W, Wu JS. Causes and diagnostic utility of musculoskeletal MRI recall examinations. Clin Radiol 2023; 78:e221-e226. [PMID: 36517267 DOI: 10.1016/j.crad.2022.11.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/24/2022] [Revised: 10/30/2022] [Accepted: 11/05/2022] [Indexed: 12/15/2022]
Abstract
AIM To determine the causes and diagnostic utility of musculoskeletal (MSK) magnetic resonance imaging (MRI) recall examinations. MATERIALS AND METHODS An institutional review board-approved retrospective review was conducted of all MSK MRI examinations performed at a single academic institution over 10 years where radiologists requested the patient return for additional imaging. The reason for the recall was documented. Recalls were reviewed in consensus by two MSK radiologists to determine whether additional sequences resulted in a change in the final report. Recall causes were divided into four categories: (1) radiologist-related: incorrect field of view (FOV) or incorrect protocol; (2) technologist-related: incorrect FOV or incorrect/incomplete protocol performed, or technically poor-quality images; (3) patient-related motion artefact; (4) unexpected lesion discovered. Fisher's exact test was used to assess for statistical significance. RESULTS The recall rate was 0.25% (156/62,930). Of the total 129 recalls returning for imaging, 42 (33%) were radiologist-related, 45 (35%) were technologist-related, six (5%) were patient-related, and 36 (28%) had an unexpected lesion requiring additional sequences. For clinical utility, 42% resulted in a change from the initial report. Recalls due to radiologist error, incorrect FOV, or unexpected lesion caused a significant change in the final report; however, recalls due to technologist error, patient motion artefact, or incorrect protocol did not. CONCLUSION MRI MSK recalls are uncommon, and the most common reasons are incorrect FOV, incorrect protocol, and unexpected lesion. Radiologist-related errors in protocols and FOV led to a significant change in the final report and should be targeted as areas for improvement to reduce recall examinations.
Collapse
Affiliation(s)
- A Komarraju
- Department of Radiology, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215, USA
| | - C Maxwell
- Scripps Clinic Medical Group, 10666 North Torrey Pines Rd, La Jolla, CA 92037, USA
| | - J W Kung
- Department of Radiology, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215, USA
| | - J N Mhuircheartaigh
- Department of Radiology, School of Medicine, University of Limerick, V94T9Pk, Ireland
| | - W Kim
- Department of Radiology, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215, USA
| | - J S Wu
- Department of Radiology, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215, USA.
| |
Collapse
|
40
|
Kim W, Kim M, Kim YT, Park W, Kim JB, Kim C, Joung B. Cost-effectiveness of rhythm control strategy: Ablation versus antiarrhythmic drugs for treating atrial fibrillation in Korea based on real-world data. Front Cardiovasc Med 2023; 10:1062578. [PMID: 36760559 PMCID: PMC9902500 DOI: 10.3389/fcvm.2023.1062578] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/06/2022] [Accepted: 01/09/2023] [Indexed: 01/26/2023] Open
Abstract
Background Ablation-based treatment has emerged as an alternative rhythm control strategy for symptomatic atrial fibrillation (AF). Recent studies have demonstrated the cost-effectiveness of ablation compared with medical therapy in various circumstances. We assessed the economic comparison between ablation and medical therapy based on a nationwide real-world population. Methods and findings For 192,345 patients with new-onset AF (age ≥ 18 years) identified between August 2015 and July 2018 from the Korean Health Insurance Review and Assessment Service (HIRA) database, medical resource use data were collected to compare AF patients that underwent ablation (N = 2,131) and those administered antiarrhythmic drugs (N = 8,048). Subsequently, a Markov chain Monte Carlo model was built. The patients had at least one risk factor for stroke, and the base-case used a 20-year time horizon, discounting at 4.5% annually. Transition probabilities and costs were estimated using the present data, and utilities were derived from literature review. The costs were converted to US $ (2019). Sensitivity analyses were performed using probabilistic and deterministic methods. The net costs and quality-adjusted life years (QALY) for antiarrhythmic drugs and ablation treatments were $37,421 and 8.8 QALYs and $39,820 and 9.3 QALYs, respectively. Compared with antiarrhythmic drugs, incremental cost-effectiveness ratio of ablation was $4,739/QALY, which is lower than the willingness-to-pay (WTP) threshold of $32,000/QALY. Conclusion In symptomatic AF patients with a stroke risk under the age of 75 years, ablation-based rhythm control is potentially a more economically attractive option compared with antiarrhythmic drug-based rhythm control in Korea.
Collapse
Affiliation(s)
- Woojin Kim
- Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea
| | - Min Kim
- Division of Cardiology, Department of Internal Medicine, Chungbuk National University Hospital, Cheongju, Republic of Korea
| | - Yun Tae Kim
- Department of Public Health, Yonsei University Graduate School, Seoul, Republic of Korea
| | - Woongbi Park
- Department of Public Health, Yonsei University Graduate School, Seoul, Republic of Korea
| | - Jin-bae Kim
- Division of Cardiology, Department of Internal Medicine, Kyung Hee University Hospital, Seoul, Republic of Korea,*Correspondence: Jin-bae Kim,
| | - Changsoo Kim
- Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea,Institute of Human Complexity and Systems Science, Yonsei University, Incheon, Republic of Korea,Changsoo Kim,
| | - Boyoung Joung
- Division of Cardiology, Department of Internal Medicine, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea,Boyoung Joung,
| |
Collapse
|
41
|
Avakian H, Hayward TB, Kotzinian A, Armstrong WR, Atac H, Ayerbe Gayoso C, Baashen L, Baltzell NA, Barion L, Bashkanov M, Battaglieri M, Bedlinskiy I, Benkel B, Benmokhtar F, Bianconi A, Biondo L, Biselli AS, Bondi M, Boiarinov S, Bossù F, Brinkman KT, Briscoe WJ, Brooks WK, Bueltmann S, Bulumulla D, Burkert VD, Capobianco R, Carman DS, Carvajal JC, Celentano A, Chatagnon P, Chesnokov V, Chetry T, Ciullo G, Cole PL, Contalbrigo M, Costantini G, D'Angelo A, Dashyan N, De Vita R, Defurne M, Deur A, Diehl S, Dilks C, Djalali C, Dupre R, Egiyan H, El Alaoui A, El Fassi L, Elouadrhiri L, Fegan S, Filippi A, Forest T, Gates K, Gavalian G, Ghandilyan Y, Glazier DI, Golubenko AA, Gosta G, Gothe RW, Gotra Y, Griffioen KA, Guidal M, Hakobyan H, Hattawy M, Hauenstein F, Heddle D, Hobart A, Holtrop M, Hyde CE, Ilieva Y, Ireland DG, Isupov EL, Jo HS, Johnston R, Joo K, Kabir ML, Keller D, Khachatryan M, Khanal A, Kim A, Kim W, Klimenko V, Kripko A, Kubarovsky V, Kuhn SE, Lagerquist V, Lanza L, Leali M, Lee S, Lenisa P, Li X, MacGregor IJD, Marchand D, Mascagna V, McKinnon B, Migliorati S, Mineeva T, Mirazita M, Mokeev V, Montgomery RA, Munoz Camacho C, Nadel-Turonski P, Naidoo P, Neupane K, Nguyen D, Niccolai S, Nicol M, Niculescu G, Osipenko M, Pandey P, Paolone M, Pappalardo LL, Paremuzyan R, Pasyuk E, Paul SJ, Phelps W, Pilleux N, Pogorelko O, Pokhrel M, Poudel J, Price JW, Prok Y, Raue BA, Reed T, Richards J, Ripani M, Ritman J, Rossi P, Sabatié F, Salgado C, Schmidt A, Sharabian YG, Shirokov EV, Shrestha U, Simmerling P, Sokhan D, Sparveris N, Stepanyan S, Strakovsky II, Strauch S, Tan JA, Trotta N, Tyson R, Ungaro M, Vallarino S, Venturelli L, Voskanyan H, Vossen A, Voutier E, Watts DP, Wei X, Wishart R, Wood MH, Zachariou N, Zhao ZW, Zurek M. Observation of Correlations between Spin and Transverse Momenta in Back-to-Back Dihadron Production at CLAS12. Phys Rev Lett 2023; 130:022501. [PMID: 36706384 DOI: 10.1103/physrevlett.130.022501] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/10/2022] [Revised: 11/07/2022] [Accepted: 12/07/2022] [Indexed: 06/18/2023]
Abstract
We report the first measurements of deep inelastic scattering spin-dependent azimuthal asymmetries in back-to-back dihadron electroproduction in the deep inelastic scattering process. In this reaction, two hadrons are produced in opposite hemispheres along the z axis in the virtual photon-target nucleon center-of-mass frame, with the first hadron produced in the current-fragmentation region and the second in the target-fragmentation region. The data were taken with longitudinally polarized electron beams of 10.2 and 10.6 GeV incident on an unpolarized liquid-hydrogen target using the CLAS12 spectrometer at Jefferson Lab. Observed nonzero sinΔϕ modulations in ep→e^{'}pπ^{+}X events, where Δϕ is the difference of the azimuthal angles of the proton and pion in the virtual photon and target nucleon center-of-mass frame, indicate that correlations between the spin and transverse momenta of hadrons produced in the target- and current-fragmentation regions may be significant. The measured beam-spin asymmetries provide a first access in dihadron production to a previously unexplored leading-twist spin- and transverse-momentum-dependent fracture function. The fracture functions describe the hadronization of the target remnant after the hard scattering of a virtual photon off a quark in the target particle and provide a new avenue for studying nucleonic structure and hadronization.
Collapse
Affiliation(s)
- H Avakian
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - T B Hayward
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - A Kotzinian
- Yerevan Physics Institute, 375036 Yerevan, Armenia
- INFN, Sezione di Torino, 10125 Torino, Italy
| | - W R Armstrong
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - H Atac
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - C Ayerbe Gayoso
- College of William and Mary, Williamsburg, Virginia 23187-8795, USA
| | - L Baashen
- Florida International University, Miami, Florida 33199, USA
| | - N A Baltzell
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - L Barion
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - M Bashkanov
- University of York, York YO10 5DD, United Kingdom
| | | | - I Bedlinskiy
- National Research Centre Kurchatov Institute-ITEP, Moscow 117259, Russia
| | - B Benkel
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
| | - F Benmokhtar
- Duquesne University, 600 Forbes Avenue, Pittsburgh, Pennsylvania 15282, USA
| | - A Bianconi
- Università degli Studi di Brescia, 25123 Brescia, Italy
- INFN, Sezione di Pavia, 27100 Pavia, Italy
| | - L Biondo
- INFN, Sezione di Genova, 16146 Genova, Italy
- INFN, Sezione di Catania, 95123 Catania, Italy
- Università degli Studi di Messina, 98166 Messina, Italy
| | - A S Biselli
- Fairfield University, Fairfield, Connecticut 06824, USA
| | - M Bondi
- INFN, Sezione di Roma Tor Vergata, 00133 Rome, Italy
| | - S Boiarinov
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - F Bossù
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - K T Brinkman
- II. Physikalisches Institut der Universität Gießen, 35392 Gießen, Germany
| | - W J Briscoe
- The George Washington University, Washington, D.C. 20052, USA
| | - W K Brooks
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
| | - S Bueltmann
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - D Bulumulla
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - V D Burkert
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - R Capobianco
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - D S Carman
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - J C Carvajal
- Florida International University, Miami, Florida 33199, USA
| | - A Celentano
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - P Chatagnon
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - V Chesnokov
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, 119234 Moscow, Russia
| | - T Chetry
- Florida International University, Miami, Florida 33199, USA
- Mississippi State University, Mississippi State, Mississippi 39762-5167, USA
- Ohio University, Athens, Ohio 45701, USA
| | - G Ciullo
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
- Università di Ferrara, 44121 Ferrara, Italy
| | - P L Cole
- Lamar University, 4400 MLK Boulevard, P.O. Box 10046, Beaumont, Texas 77710, USA
| | | | - G Costantini
- Università degli Studi di Brescia, 25123 Brescia, Italy
- INFN, Sezione di Pavia, 27100 Pavia, Italy
| | - A D'Angelo
- INFN, Sezione di Roma Tor Vergata, 00133 Rome, Italy
- Università di Roma Tor Vergata, 00133 Rome, Italy
| | - N Dashyan
- Yerevan Physics Institute, 375036 Yerevan, Armenia
| | - R De Vita
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - M Defurne
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - A Deur
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S Diehl
- University of Connecticut, Storrs, Connecticut 06269, USA
- II. Physikalisches Institut der Universität Gießen, 35392 Gießen, Germany
| | - C Dilks
- Duke University, Durham, North Carolina 27708-0305, USA
| | - C Djalali
- Ohio University, Athens, Ohio 45701, USA
| | - R Dupre
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - H Egiyan
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - A El Alaoui
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
| | - L El Fassi
- Mississippi State University, Mississippi State, Mississippi 39762-5167, USA
| | - L Elouadrhiri
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S Fegan
- University of York, York YO10 5DD, United Kingdom
| | - A Filippi
- INFN, Sezione di Torino, 10125 Torino, Italy
| | - T Forest
- Idaho State University, Pocatello, Idaho 83209, USA
| | - K Gates
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - G Gavalian
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - Y Ghandilyan
- Yerevan Physics Institute, 375036 Yerevan, Armenia
| | - D I Glazier
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - A A Golubenko
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, 119234 Moscow, Russia
| | - G Gosta
- Università degli Studi di Brescia, 25123 Brescia, Italy
- INFN, Sezione di Pavia, 27100 Pavia, Italy
| | - R W Gothe
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - Y Gotra
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - K A Griffioen
- College of William and Mary, Williamsburg, Virginia 23187-8795, USA
| | - M Guidal
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - H Hakobyan
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
| | - M Hattawy
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - F Hauenstein
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - D Heddle
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
- Christopher Newport University, Newport News, Virginia 23606, USA
| | - A Hobart
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - M Holtrop
- University of New Hampshire, Durham, New Hampshire 03824-3568, USA
| | - C E Hyde
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - Y Ilieva
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - D G Ireland
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - E L Isupov
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, 119234 Moscow, Russia
| | - H S Jo
- Kyungpook National University, Daegu 41566, Republic of Korea
| | - R Johnston
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307, USA
| | - K Joo
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - M L Kabir
- Mississippi State University, Mississippi State, Mississippi 39762-5167, USA
| | - D Keller
- University of Virginia, Charlottesville, Virginia 22901, USA
| | - M Khachatryan
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - A Khanal
- Florida International University, Miami, Florida 33199, USA
| | - A Kim
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - W Kim
- Kyungpook National University, Daegu 41566, Republic of Korea
| | - V Klimenko
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - A Kripko
- II. Physikalisches Institut der Universität Gießen, 35392 Gießen, Germany
| | - V Kubarovsky
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S E Kuhn
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - V Lagerquist
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - L Lanza
- INFN, Sezione di Roma Tor Vergata, 00133 Rome, Italy
| | - M Leali
- Università degli Studi di Brescia, 25123 Brescia, Italy
- INFN, Sezione di Pavia, 27100 Pavia, Italy
| | - S Lee
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307, USA
| | - P Lenisa
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
- Università di Ferrara, 44121 Ferrara, Italy
| | - X Li
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307, USA
| | | | - D Marchand
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - V Mascagna
- Università degli Studi di Brescia, 25123 Brescia, Italy
- INFN, Sezione di Pavia, 27100 Pavia, Italy
| | - B McKinnon
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - S Migliorati
- Università degli Studi di Brescia, 25123 Brescia, Italy
- INFN, Sezione di Pavia, 27100 Pavia, Italy
| | - T Mineeva
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
| | - M Mirazita
- INFN, Laboratori Nazionali di Frascati, 00044 Frascati, Italy
| | - V Mokeev
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | | | - C Munoz Camacho
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - P Nadel-Turonski
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - P Naidoo
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - K Neupane
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - D Nguyen
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S Niccolai
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - M Nicol
- University of York, York YO10 5DD, United Kingdom
| | - G Niculescu
- James Madison University, Harrisonburg, Virginia 22807, USA
| | - M Osipenko
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - P Pandey
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - M Paolone
- Temple University, Philadelphia, Pennsylvania 19122, USA
- New Mexico State University, P.O. Box 30001, Las Cruces, New Mexico 88003, USA
| | - L L Pappalardo
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
- Università di Ferrara, 44121 Ferrara, Italy
| | - R Paremuzyan
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
- University of New Hampshire, Durham, New Hampshire 03824-3568, USA
| | - E Pasyuk
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S J Paul
- University of California Riverside, 900 University Avenue, Riverside, California 92521, USA
| | - W Phelps
- The George Washington University, Washington, D.C. 20052, USA
- Christopher Newport University, Newport News, Virginia 23606, USA
| | - N Pilleux
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - O Pogorelko
- National Research Centre Kurchatov Institute-ITEP, Moscow 117259, Russia
| | - M Pokhrel
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - J Poudel
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - J W Price
- California State University, Dominguez Hills, Carson, California 90747, USA
| | - Y Prok
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - B A Raue
- Florida International University, Miami, Florida 33199, USA
| | - T Reed
- Florida International University, Miami, Florida 33199, USA
| | - J Richards
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - M Ripani
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - J Ritman
- GSI Helmholtzzentrum fur Schwerionenforschung GmbH, D-64291 Darmstadt, Germany
- Institute fur Kernphysik (Juelich), 52428 Juelich, Germany
| | - P Rossi
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
- INFN, Laboratori Nazionali di Frascati, 00044 Frascati, Italy
| | - F Sabatié
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - C Salgado
- Norfolk State University, Norfolk, Virginia 23504, USA
| | - A Schmidt
- The George Washington University, Washington, D.C. 20052, USA
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307, USA
| | - Y G Sharabian
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - E V Shirokov
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, 119234 Moscow, Russia
| | - U Shrestha
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - P Simmerling
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - D Sokhan
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - N Sparveris
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - S Stepanyan
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - I I Strakovsky
- The George Washington University, Washington, D.C. 20052, USA
| | - S Strauch
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - J A Tan
- Kyungpook National University, Daegu 41566, Republic of Korea
| | - N Trotta
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - R Tyson
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - M Ungaro
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S Vallarino
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - L Venturelli
- Università degli Studi di Brescia, 25123 Brescia, Italy
- INFN, Sezione di Pavia, 27100 Pavia, Italy
| | - H Voskanyan
- Yerevan Physics Institute, 375036 Yerevan, Armenia
| | - A Vossen
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
- Duke University, Durham, North Carolina 27708-0305, USA
| | - E Voutier
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - D P Watts
- University of York, York YO10 5DD, United Kingdom
| | - X Wei
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - R Wishart
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - M H Wood
- Canisius College, Buffalo, New York 14208, USA
| | - N Zachariou
- University of York, York YO10 5DD, United Kingdom
| | - Z W Zhao
- Duke University, Durham, North Carolina 27708-0305, USA
| | - M Zurek
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| |
Collapse
|
42
|
Park JK, Lee H, Kim W, Kim GM, An D. Degradation Feature Extraction Method for Prognostics of an Extruder Screw Using Multi-Source Monitoring Data. Sensors (Basel) 2023; 23:637. [PMID: 36679434 PMCID: PMC9863292 DOI: 10.3390/s23020637] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 11/15/2022] [Revised: 12/13/2022] [Accepted: 12/30/2022] [Indexed: 06/17/2023]
Abstract
Laboratory-scale data on a component level are frequently used for prognostics because acquiring them is time and cost efficient. However, they do not reflect actual field conditions. As prognostics is for an in-service system, the developed prognostic methods must be validated using real operational data obtained from an actual system. Because obtaining real operational data is much more expensive than obtaining test-level data, studies employing field data are scarce. In this study, a prognostic method for screws was presented by employing multi-source real operational data obtained from a micro-extrusion system. The analysis of real operational data is more challenging than that of test-level data because the mutual effect of each component in the system is chaotically reflected in the former. This paper presents a degradation feature extraction method for interpreting complex signals for a real extrusion system based on the physical and mechanical properties of the system as well as operational data. The data were analyzed based on general physical properties and the inferred interpretation was verified using the data. The extracted feature exhibits valid degradation behavior and is used to predict the remaining useful life of the screw in a real extrusion system.
Collapse
Affiliation(s)
- Jun-Kyu Park
- Renewable Energy Solution Group, Korea Electric Power Research Institute, Naju 58277, Republic of Korea
| | - Howon Lee
- Advanced Mechatronics R&D Group, Korea Institute of Industrial Technology, Daegu 42994, Republic of Korea
- School of Mechanical Engineering, Kyungpook National University, Daegu 41566, Republic of Korea
| | - Woojin Kim
- Advanced Mechatronics R&D Group, Korea Institute of Industrial Technology, Daegu 42994, Republic of Korea
| | - Gyu-Man Kim
- School of Mechanical Engineering, Kyungpook National University, Daegu 41566, Republic of Korea
| | - Dawn An
- Advanced Mechatronics R&D Group, Korea Institute of Industrial Technology, Daegu 42994, Republic of Korea
| |
Collapse
|
43
|
Park KT, Kim S, Choi I, Han IH, Bae H, Kim W. The involvement of the noradrenergic system in the antinociceptive effect of cucurbitacin D on mice with paclitaxel-induced neuropathic pain. Front Pharmacol 2023; 13:1055264. [PMID: 36686685 PMCID: PMC9846532 DOI: 10.3389/fphar.2022.1055264] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2022] [Accepted: 12/12/2022] [Indexed: 01/05/2023] Open
Abstract
Paclitaxel (sold under the brand name Taxol) is a chemotherapeutic drug that is widely used to treat cancer. However, it can also induce peripheral neuropathy, which limits its use. Although several drugs are used to attenuate neuropathy, no optimal treatment is available to date. In this study, the effect of cucurbitacins B and D on paclitaxel-induced neuropathic pain was assessed. Multiple paclitaxel injections (a cumulative dose of 8 mg/kg, i. p.) induced cold and mechanical allodynia from days 10 to 21 in mice, and the i. p. administration of 0.025 mg/kg of cucurbitacins B and D attenuated both allodynia types. However, as cucurbitacin B showed a more toxic effect on non-cancerous (RAW 264.7) cells, further experiments were conducted with cucurbitacin D. The cucurbitacin D dose-dependently (0.025, 0.1, and 0.5 mg/kg) attenuated both allodynia types. In the spinal cord, paclitaxel injection increased the gene expression of noradrenergic (α 1-and α 2-adrenergic) receptors but not serotonergic (5-HT1A and 3) receptors. Cucurbitacin D treatment significantly decreased the spinal α 1- but not α 2-adrenergic receptors, and the amount of spinal noradrenaline was also downregulated. However, the tyrosine hydroxylase expression measured via liquid chromatography in the locus coeruleus did not decrease significantly. Finally, cucurbitacin D treatment did not lower the anticancer effect of chemotherapeutic drugs when co-administered with paclitaxel in CT-26 cell-implanted mice. Altogether, these results suggest that cucurbitacin D could be considered a treatment option against paclitaxel-induced neuropathic pain.
Collapse
Affiliation(s)
- Keun-Tae Park
- Department of Physiology, College of Korean Medicine, Kyung Hee University, Seoul, South Korea
| | - Suyong Kim
- Department of Physiology, College of Korean Medicine, Kyung Hee University, Seoul, South Korea
| | - Ilseob Choi
- Department of Physiology, College of Korean Medicine, Kyung Hee University, Seoul, South Korea
| | - Ik-Hwan Han
- Department of Physiology, College of Korean Medicine, Kyung Hee University, Seoul, South Korea
| | - Hyunsu Bae
- Department of Physiology, College of Korean Medicine, Kyung Hee University, Seoul, South Korea
| | - Woojin Kim
- Department of Physiology, College of Korean Medicine, Kyung Hee University, Seoul, South Korea,Korean Medicine-Based Drug Repositioning Cancer Research Center, College of Korean Medicine, Kyung Hee University, Seoul, South Korea,*Correspondence: Woojin Kim,
| |
Collapse
|
44
|
Shin Y, Kim B, Kim W. Cisplatin-Induced Nausea and Vomiting: Effect of Herbal Medicines. Plants (Basel) 2022; 11:3395. [PMID: 36501434 PMCID: PMC9736559 DOI: 10.3390/plants11233395] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 10/11/2022] [Revised: 11/26/2022] [Accepted: 12/02/2022] [Indexed: 06/17/2023]
Abstract
Cisplatin is a chemotherapeutic agent that is widely used to treat various types of cancers. However, its side effects, most commonly nausea and vomiting, limit its widespread use. Although various drugs, such as ondansetron and aprepitant, are used to alleviate these side effects, their efficacy is still debated. This review aims to summarize the results of 14 studies on the effects of seven single herbal extracts, one multiple herbal extract, and one ginger sub-component (i.e., [6]-gingerol) on cisplatin-induced nausea and vomiting. The results of the included studies were subdivided into four categories: kaolin consumption, retching and vomiting, food intake, and weight loss. Most studies used rodents, whereas four studies used minks or pigeons. The doses of cisplatin used in the studies varied from 3 mg/kg to 7.5 mg/kg, and only a single injection was used. Nine studies analyzed the mechanisms of action of herbal medicines and assessed the involvement of neurotransmitters, cytokines, enzymes, and various hematological parameters. Although further research is needed, this review suggests herbal medicine as a viable treatment option for cisplatin-induced neuropathic pain.
Collapse
Affiliation(s)
- Yuchan Shin
- Department of Physiology, College of Korean Medicine, Kyung Hee University, Seoul 02447, Republic of Korea
| | - Bonglee Kim
- Korean Medicine-Based Drug Repositioning Cancer Research Center, College of Korean Medicine, Kyung Hee University, Seoul 02447, Republic of Korea
| | - Woojin Kim
- Department of Physiology, College of Korean Medicine, Kyung Hee University, Seoul 02447, Republic of Korea
- Korean Medicine-Based Drug Repositioning Cancer Research Center, College of Korean Medicine, Kyung Hee University, Seoul 02447, Republic of Korea
| |
Collapse
|
45
|
Kim W, Jang D, Kim H, Kim Y, Kim HJ. Real-time analysis of Ni-rich layered oxide-electrolyte reactivity by observing leakage currents. Electrochim Acta 2022. [DOI: 10.1016/j.electacta.2022.141285] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
46
|
Lee SJ, Baek SK, Kim W, Quah Y, Kim SY, Jeong JS, Lee J, Yu WJ. Reproductive and developmental toxicity screening of bisphenol F by oral gavage in rats. Regul Toxicol Pharmacol 2022; 136:105286. [DOI: 10.1016/j.yrtph.2022.105286] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/26/2022] [Revised: 09/25/2022] [Accepted: 11/06/2022] [Indexed: 11/13/2022]
|
47
|
Kim M, Lee D, Kim W, Eun Lee J, Lee J, Tae Kim Y, Lee SK, Soo Oh S, Soo Park K, Baek Koh S, Kim C, Jung YC. Associations between altered functional connectivity of attentional networks and sleep quality among firefighters. Neurosci Lett 2022; 791:136924. [DOI: 10.1016/j.neulet.2022.136924] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2022] [Revised: 10/14/2022] [Accepted: 10/17/2022] [Indexed: 10/31/2022]
|
48
|
Yoo MH, Lee SJ, Kim W, Kim Y, Kim YB, Moon KS, Lee BS. Bisphenol A impairs renal function by reducing Na +/K +-ATPase and F-actin expression, kidney tubule formation in vitro and in vivo. Ecotoxicol Environ Saf 2022; 246:114141. [PMID: 36206637 DOI: 10.1016/j.ecoenv.2022.114141] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/18/2022] [Revised: 09/19/2022] [Accepted: 09/28/2022] [Indexed: 05/26/2023]
Abstract
The kidney proximal tubule is responsible for reabsorbing water and NaCl to maintain the homeostasis of the body fluids, electrolytes, and nutrients. Thus, abnormal functioning of the renal proximal tubule can lead to life-threatening imbalances. Bisphenol A (BPA) has been used for decades as a representative chemical in household plastic products, but studies on its effects on the kidney proximal tubule are insufficient. In this study, immunocytochemical and cytotoxicity tests were performed using two- and three-dimensional human renal proximal tubular epithelial cell (hRPTEC) cultures to investigate the impact of low-dose BPA (1-10 μM) exposure. BPA was found to interfere with straight tubule formation as observed by low filamentous actin formation and reduced Na+/K+-ATPase expression in the tubules of hRPTEC 3D cultures. Similar results were observed in rat pup kidneys following oral administration of 250 mg/kg BPA. Moreover, the expression of HO-1 and 8-OHdG, key markers for oxidative stress, was increased in vitro and in vivo following BPA administration, whereas that of OAT1 and OAT, important transporters of the renal proximal tubules, was not altered. Overall, no-observed-adverse-effect-level (NOAEL)-dose BPA exposure can decrease renal function by promoting abnormal tubular formation both in vitro and in vivo. Therefore, we propose that although it does not exhibit life-threatening toxicity, exposure to low levels of BPA can negatively affect homeostasis in the body by means of long-term deterioration of renal proximal tubular function in humans.
Collapse
Affiliation(s)
- Min Heui Yoo
- Department of Advanced Toxicology Research, Korea Institute of Toxicology, Daejeon, Republic of Korea.
| | - Seung-Jin Lee
- Department of Advanced Toxicology Research, Korea Institute of Toxicology, Daejeon, Republic of Korea.
| | - Woojin Kim
- Department of Advanced Toxicology Research, Korea Institute of Toxicology, Daejeon, Republic of Korea.
| | - Younhee Kim
- Department of Advanced Toxicology Research, Korea Institute of Toxicology, Daejeon, Republic of Korea.
| | - Yong-Bum Kim
- Department of Advanced Toxicology Research, Korea Institute of Toxicology, Daejeon, Republic of Korea.
| | - Kyoung-Sik Moon
- Department of Advanced Toxicology Research, Korea Institute of Toxicology, Daejeon, Republic of Korea.
| | - Byoung-Seok Lee
- Department of Advanced Toxicology Research, Korea Institute of Toxicology, Daejeon, Republic of Korea.
| |
Collapse
|
49
|
Paul SJ, Morán S, Arratia M, El Alaoui A, Hakobyan H, Brooks W, Amaryan MJ, Armstrong WR, Atac H, Baashen L, Baltzell NA, Barion L, Bashkanov M, Battaglieri M, Bedlinskiy I, Benkel B, Benmokhtar F, Bianconi A, Biondo L, Biselli AS, Bondi M, Bossù F, Boiarinov S, Brinkmann KT, Briscoe WJ, Bulumulla D, Burkert VD, Capobianco R, Carman DS, Celentano A, Chesnokov V, Chetry T, Ciullo G, Cole PL, Contalbrigo M, Costantini G, D'Angelo A, Dashyan N, De Vita R, Defurne M, Deur A, Diehl S, Dilks C, Djalali C, Dupre R, Egiyan H, El Fassi L, Eugenio P, Fegan S, Filippi A, Gavalian G, Ghandilyan Y, Gilfoyle GP, Golubenko AA, Gosta G, Gothe RW, Griffioen KA, Guidal M, Hattawy M, Hayward TB, Heddle D, Hobart A, Holtrop M, Ilieva Y, Ireland DG, Isupov EL, Jo HS, Johnston R, Joo K, Joosten S, Keller D, Khanal A, Khandaker M, Kim W, Kripko A, Kubarovsky V, Lagerquist V, Lanza L, Leali M, Lee S, Lenisa P, Li X, Livingston K, MacGregor IJD, Marchand D, Mascagna V, McKinnon B, Meziani ZE, Migliorati S, Milner RG, Mineeva T, Mirazita M, Mokeev VI, Moran P, Munoz Camacho C, Neupane K, Nguyen D, Niccolai S, Niculescu G, Osipenko M, Ostrovidov AI, Pandey P, Paolone M, Pappalardo LL, Paremuzyan R, Pasyuk E, Phelps W, Pilleux N, Pocanic D, Pogorelko O, Pokhrel M, Poudel J, Price JW, Prok Y, Raue BA, Reed T, Ripani M, Rosner G, Sabatié F, Salgado C, Schmidt A, Schumacher RA, Sharabian YG, Shirokov EV, Shrestha U, Simmerling P, Sokhan D, Sparveris N, Stepanyan S, Strakovsky II, Strauch S, Tan JA, Tyson R, Ungaro M, Vallarino S, Venturelli L, Voskanyan H, Voutier E, Wei X, Wishart R, Wood MH, Zachariou N, Zhao ZW, Ziegler V, Zurek M. Observation of Azimuth-Dependent Suppression of Hadron Pairs in Electron Scattering off Nuclei. Phys Rev Lett 2022; 129:182501. [PMID: 36374671 DOI: 10.1103/physrevlett.129.182501] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/19/2022] [Revised: 08/26/2022] [Accepted: 09/30/2022] [Indexed: 06/16/2023]
Abstract
We present the first measurement of dihadron angular correlations in electron-nucleus scattering. The data were taken with the CLAS detector and a 5.0 GeV electron beam incident on deuterium, carbon, iron, and lead targets. Relative to deuterium, the nuclear yields of charged-pion pairs show a strong suppression for azimuthally opposite pairs, no suppression for azimuthally nearby pairs, and an enhancement of pairs with large invariant mass. These effects grow with increased nuclear size. The data are qualitatively described by the gibuu model, which suggests that hadrons form near the nuclear surface and undergo multiple scattering in nuclei.These results show that angular correlation studies can open a new way to elucidate how hadrons form and interact inside nuclei.
Collapse
Affiliation(s)
- S J Paul
- University of California Riverside, 900 University Avenue, Riverside, California 92521, USA
| | - S Morán
- University of California Riverside, 900 University Avenue, Riverside, California 92521, USA
| | - M Arratia
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
- University of California Riverside, 900 University Avenue, Riverside, California 92521, USA
| | - A El Alaoui
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
| | - H Hakobyan
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
| | - W Brooks
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
| | - M J Amaryan
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - W R Armstrong
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - H Atac
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - L Baashen
- Florida International University, Miami, Florida 33199, USA
| | - N A Baltzell
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - L Barion
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - M Bashkanov
- University of York, York YO10 5DD, United Kingdom
| | | | - I Bedlinskiy
- National Research Centre Kurchatov Institute-ITEP, Moscow, 117259, Russia
| | - B Benkel
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
| | - F Benmokhtar
- Duquesne University, 600 Forbes Avenue, Pittsburgh, Pennsylvania 15282, USA
| | - A Bianconi
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Brescia, 25123 Brescia, Italy
| | - L Biondo
- INFN, Sezione di Genova, 16146 Genova, Italy
- INFN, Sezione di Catania, 95123 Catania, Italy
- Università degli Studi di Messina, 98166 Messina, Italy
| | - A S Biselli
- Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA
- Fairfield University, Fairfield, Connecticut 06824, USA
| | - M Bondi
- INFN, Sezione di Roma Tor Vergata, 00133 Rome, Italy
| | - F Bossù
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - S Boiarinov
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - K-Th Brinkmann
- II Physikalisches Institut der Universitaet Giessen, 35392 Giessen, Germany
| | - W J Briscoe
- The George Washington University, Washington, D.C. 20052, USA
| | - D Bulumulla
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - V D Burkert
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - R Capobianco
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - D S Carman
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - A Celentano
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - V Chesnokov
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, 119234 Moscow, Russia
| | - T Chetry
- Florida International University, Miami, Florida 33199, USA
| | - G Ciullo
- Università di Ferrara, 44121 Ferrara, Italy
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - P L Cole
- Catholic University of America, Washington, D.C. 20064, USA
- Lamar University, 4400 MLK Blvd, P.O. Box 10046, Beaumont, Texas 77710, USA
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | | | - G Costantini
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Brescia, 25123 Brescia, Italy
| | - A D'Angelo
- INFN, Sezione di Roma Tor Vergata, 00133 Rome, Italy
- Università di Roma Tor Vergata, 00133 Rome Italy
| | - N Dashyan
- Yerevan Physics Institute, 375036 Yerevan, Armenia
| | - R De Vita
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - M Defurne
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - A Deur
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S Diehl
- University of Connecticut, Storrs, Connecticut 06269, USA
- II Physikalisches Institut der Universitaet Giessen, 35392 Giessen, Germany
| | - C Dilks
- Duke University, Durham, North Carolina 27708-0305, USA
| | - C Djalali
- Ohio University, Athens, Ohio 45701, USA
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - R Dupre
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - H Egiyan
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - L El Fassi
- Mississippi State University, Mississippi State, Mississippi 39762-5167, USA
| | - P Eugenio
- Florida State University, Tallahassee, Florida 32306, USA
| | - S Fegan
- University of York, York YO10 5DD, United Kingdom
| | - A Filippi
- INFN, Sezione di Torino, 10125 Torino, Italy
| | - G Gavalian
- University of New Hampshire, Durham, New Hampshire 03824-3568, USA
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - Y Ghandilyan
- Yerevan Physics Institute, 375036 Yerevan, Armenia
| | - G P Gilfoyle
- University of Richmond, Richmond, Virginia 23173, USA
| | - A A Golubenko
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, 119234 Moscow, Russia
| | - G Gosta
- Università degli Studi di Brescia, 25123 Brescia, Italy
| | - R W Gothe
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - K A Griffioen
- College of William and Mary, Williamsburg, Virginia 23187-8795, USA
| | - M Guidal
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - M Hattawy
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - T B Hayward
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - D Heddle
- Christopher Newport University, Newport News, Virginia 23606, USA
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - A Hobart
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - M Holtrop
- University of New Hampshire, Durham, New Hampshire 03824-3568, USA
| | - Y Ilieva
- The George Washington University, Washington, D.C. 20052, USA
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - D G Ireland
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - E L Isupov
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, 119234 Moscow, Russia
| | - H S Jo
- Kyungpook National University, Daegu 41566, Republic of Korea
| | - R Johnston
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307, USA
| | - K Joo
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - S Joosten
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - D Keller
- University of Virginia, Charlottesville, Virginia 22901, USA
| | - A Khanal
- Florida International University, Miami, Florida 33199, USA
| | - M Khandaker
- Norfolk State University, Norfolk, Virginia 23504, USA
| | - W Kim
- Kyungpook National University, Daegu 41566, Republic of Korea
| | - A Kripko
- II Physikalisches Institut der Universitaet Giessen, 35392 Giessen, Germany
| | - V Kubarovsky
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - V Lagerquist
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - L Lanza
- INFN, Sezione di Roma Tor Vergata, 00133 Rome, Italy
| | - M Leali
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Brescia, 25123 Brescia, Italy
| | - S Lee
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307, USA
| | - P Lenisa
- Università di Ferrara, 44121 Ferrara, Italy
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - X Li
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307, USA
| | - K Livingston
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | | | - D Marchand
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - V Mascagna
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Brescia, 25123 Brescia, Italy
| | - B McKinnon
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - Z E Meziani
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - S Migliorati
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Brescia, 25123 Brescia, Italy
| | - R G Milner
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307, USA
| | - T Mineeva
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
| | - M Mirazita
- INFN, Laboratori Nazionali di Frascati, 00044 Frascati, Italy
| | - V I Mokeev
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - P Moran
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307, USA
| | - C Munoz Camacho
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - K Neupane
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - D Nguyen
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S Niccolai
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - G Niculescu
- James Madison University, Harrisonburg, Virginia 22807, USA
| | - M Osipenko
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - A I Ostrovidov
- Florida State University, Tallahassee, Florida 32306, USA
| | - P Pandey
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - M Paolone
- New Mexico State University, PO Box 30001, Las Cruces, New Mexico 88003, USA
| | - L L Pappalardo
- Università di Ferrara, 44121 Ferrara, Italy
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - R Paremuzyan
- University of New Hampshire, Durham, New Hampshire 03824-3568, USA
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - E Pasyuk
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - W Phelps
- Christopher Newport University, Newport News, Virginia 23606, USA
| | - N Pilleux
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - D Pocanic
- University of Virginia, Charlottesville, Virginia 22901, USA
| | - O Pogorelko
- National Research Centre Kurchatov Institute-ITEP, Moscow, 117259, Russia
| | - M Pokhrel
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - J Poudel
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - J W Price
- California State University, Dominguez Hills, Carson, California 90747, USA
| | - Y Prok
- Old Dominion University, Norfolk, Virginia 23529, USA
- University of Virginia, Charlottesville, Virginia 22901, USA
| | - B A Raue
- Florida International University, Miami, Florida 33199, USA
| | - T Reed
- Florida International University, Miami, Florida 33199, USA
| | - M Ripani
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - G Rosner
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - F Sabatié
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - C Salgado
- Norfolk State University, Norfolk, Virginia 23504, USA
| | - A Schmidt
- The George Washington University, Washington, D.C. 20052, USA
| | - R A Schumacher
- Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA
| | - Y G Sharabian
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - E V Shirokov
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, 119234 Moscow, Russia
| | - U Shrestha
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - P Simmerling
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - D Sokhan
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - N Sparveris
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - S Stepanyan
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - I I Strakovsky
- The George Washington University, Washington, D.C. 20052, USA
| | - S Strauch
- The George Washington University, Washington, D.C. 20052, USA
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - J A Tan
- Kyungpook National University, Daegu 41566, Republic of Korea
| | - R Tyson
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - M Ungaro
- Rensselaer Polytechnic Institute, Troy, New York 12180-3590, USA
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S Vallarino
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - L Venturelli
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Brescia, 25123 Brescia, Italy
| | - H Voskanyan
- Yerevan Physics Institute, 375036 Yerevan, Armenia
| | - E Voutier
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - X Wei
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - R Wishart
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - M H Wood
- Canisius College, Buffalo, New York 14208, USA
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - N Zachariou
- University of York, York YO10 5DD, United Kingdom
| | - Z W Zhao
- Duke University, Durham, North Carolina 27708-0305, USA
| | - V Ziegler
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - M Zurek
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| |
Collapse
|
50
|
Abdelshafy M, Soliman O, Kim W, Ruck A, Elkoumy A, Elzomor H, Wang R, Tao L, Garg S, Mylotte D, Onuma Y, Serruys P. Quantitative angiographic assessment of aortic regurgitation post 11 different types of TAVI devices a multicentre pooled analysis of 2665 valves. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.2078] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Regurgitation following TAVR impacts all-cause mortality. So far, no quantitative comparison of regurgitation by the same core lab has been performed among the various commercially available transcatheter heart valves (THV) We aimed to compare quantitative angiographic aortic regurgitation (AR) of 11 different types of THVs.
Method
This is a multicentre retrospective corelab pooled analysis of aortograms from 2704 consecutive patients treated with 11 different THV devices. Analysis was done by quantitative videodensitometric aortography (LVOT-AR), which is an objective, accurate, and reproducible tool for assessment of AR following TAVR. This method relies on time density changes in contrast medium after injection in the ascending aorta and its regurgitation (and subsequent density increase) in the LVOT. The ratio between the areas under the two-time density curves of these regions quantifies the AR in absolute percentage. The valves evaluated include ACURATE neo2 (n=120), Lotus (n=546), Myval (n=108), VitaFlow (n=105), Evolut PRO (n=95), SAPIEN 3 (n=397), Evolut R (n=295), SAPIEN XT (n=239), ACURATE neo (n=120), Venus-A (n=113) and CoreValve (n=532). Stratification of continuous variable regurgitation into categorical variables was performed according to the following pre-determined threshold criteria: 1) none/trace regurgitation (LVOT-AR<6%); 2) mild (6%≤ LVOT-AR ≤17%); and 3) moderate or severe (LVOT-AR >17%).
Results
The addition of anti PVR sealing features to the new generations ACURATE neo2 THV proved to be effective in reduction the incidence of significant PVR In comparison with the first generation ACURATE neo.
Myval, VitaFlow and Venus-A THVs are showing promising results.
Although the incidence of moderate/severe AR has regressed over time with new generations of THVs, the incidence of mild AR is still prominent with all THVs still exhibiting mild AR with an incidence ranging between 30% and 50% with the exception of the Lotus valve that had an 19% incidence of mild AR
Conclusion
ACURATE neo2 had the lowest severe/moderate percentage of AR showing significant improvements in comparison to ACURATE neo. Myval, VitaFlow and Venus-A are promising options in the THV armamentarium. These results should be confirmed in prospective randomized, head-to-head comparisons between THVs.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- M Abdelshafy
- National University of Ireland , Galway , Ireland
| | - O Soliman
- National University of Ireland , Galway , Ireland
| | - W Kim
- Kerckhoff Heart and Thorax Center , Bad Nauheim , Germany
| | - A Ruck
- Karolinska Institute , Stockholm , Sweden
| | - A Elkoumy
- National University of Ireland , Galway , Ireland
| | - H Elzomor
- National University of Ireland , Galway , Ireland
| | - R Wang
- Xijing Hospital of the Fourth Military Medical University , Xi'an , China
| | - L Tao
- Xijing Hospital of the Fourth Military Medical University , Xi'an , China
| | - S Garg
- Royal Blackburn Hospital , Blackburn , United Kingdom
| | - D Mylotte
- National University of Ireland , Galway , Ireland
| | - Y Onuma
- National University of Ireland , Galway , Ireland
| | - P Serruys
- National University of Ireland , Galway , Ireland
| |
Collapse
|